{"gene":"BIK","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":1995,"finding":"BIK was identified as a novel pro-apoptotic protein that interacts with anti-apoptotic proteins BCL-2, BCL-XL, EBV-BHRF1, and adenovirus E1B-19K via a conserved 9 amino acid BH3 domain. Death-promoting activity of BIK can be suppressed by co-expression of these survival proteins.","method":"Co-immunoprecipitation, yeast two-hybrid, transient transfection apoptosis assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal binding demonstrated by multiple methods (Co-IP and two-hybrid), replicated in subsequent papers across multiple labs","pmids":["7478623"],"is_preprint":false},{"year":1996,"finding":"NBK/BIK was cloned from a yeast two-hybrid screen for proteins interacting with E1B 19K. It contains only BH3 (not BH1/BH2), interacts with BCL-2 and E1B 19K in vitro, co-localizes with cytoplasmic and nuclear membranes, antagonizes 19K-mediated inhibition of apoptosis, and induces apoptosis independently of BAX.","method":"Yeast two-hybrid, in vitro binding, transient transfection, co-localization, functional apoptosis assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods; independently replicated by other labs","pmids":["8816500"],"is_preprint":false},{"year":1997,"finding":"Functional dissection showed that the BH3 domain of BIK (residues 57-74) is the core heterodimerization domain for BCL-2 and BCL-XL, but heterodimerization alone is insufficient for cell death; additional C-terminal sequences (residues 120-134 beyond the BH3) are required for efficient apoptotic activity.","method":"Deletion mutagenesis, yeast two-hybrid, co-immunoprecipitation, functional apoptosis assays in mammalian cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic mutagenesis with functional validation, clear structure-function dissection","pmids":["9305912"],"is_preprint":false},{"year":1997,"finding":"BIK and BAK engage the apoptotic death pathway downstream of the CrmA block but upstream of the IAP (inhibitor of apoptosis) block, positioning them in the mid-stream of caspase activation cascade.","method":"Genetic epistasis using CrmA and IAP overexpression combined with BIK/BAK transfection and cell death assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean epistasis experiment, single lab, single method","pmids":["9082997"],"is_preprint":false},{"year":2000,"finding":"BIK is a phosphoprotein phosphorylated at threonine 33 and serine 35. Mutation of these phosphorylation sites (T33A/S35A) reduces apoptotic activity without significantly affecting heterodimerization with BCL-2, indicating phosphorylation is required for efficient apoptotic function. Partial purification of kinase activity from HeLa cell cytoplasm suggests a casein kinase II-related enzyme phosphorylates BIK.","method":"Metabolic 32P labeling, site-directed mutagenesis, kinase assays, functional apoptosis assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct phosphorylation mapping by mutagenesis plus functional consequence, single lab but multiple orthogonal methods","pmids":["11084041"],"is_preprint":false},{"year":2000,"finding":"The human BIK gene is located at chromosome 22q13.3, spans ~19 kb, comprises 5 exons, and is expressed ubiquitously with elevated levels in heart and skeletal muscle. A minimal promoter was localized to -211 to +153 lacking TATA/CAAT boxes.","method":"FISH, genomic cloning, Northern blot, promoter-reporter transfection, deletion mutagenesis","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — FISH for chromosomal localization, functional promoter mapping by reporter assay","pmids":["10974546"],"is_preprint":false},{"year":2002,"finding":"BIK is an ER-resident protein (containing a C-terminal transmembrane segment) that stimulates cytochrome c release from mitochondria. A BH3-domain-dependent mechanism is required. Restricting BIK to the ER membrane with a cytochrome b5 anchor retains its cytochrome c release activity. ER BIK activity requires ER/light membrane fractions and cytosol in an in vitro reconstitution assay.","method":"Subcellular fractionation, membrane anchor replacement, in vitro reconstitution, cytochrome c release assay, BH3 mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution in vitro, mutagenesis, and organelle-targeting experiments; replicated by multiple subsequent papers","pmids":["11884414"],"is_preprint":false},{"year":2002,"finding":"BIK/NBK is transcriptionally induced downstream of E1A in a p53-dependent manner. BIK induces caspase-dependent cell death in p53-null cells. A BH3 point mutation abrogates BIK function. Endogenous and ectopic BIK associates with the endoplasmic reticulum.","method":"DNA microarray, RT-PCR, Western blot, subcellular fractionation, BH3 domain mutagenesis, apoptosis assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods in single lab; consistent with multiple independent studies","pmids":["11971188"],"is_preprint":false},{"year":2003,"finding":"NBK/BIK-induced apoptosis requires BAX but not BAK; BIK expression causes a conformational switch in BAX N-terminus, cytochrome c release, and mitochondrial permeability transition. Immunoprecipitation shows BIK interacts with BCL-XL and BCL-2 but NOT with BAX directly. BIK does not localize to mitochondria, suggesting it acts indirectly as a 'sensitizer' to trigger BAX-dependent apoptosis.","method":"Adenoviral tetracycline-regulated expression, BAX-knockout/reconstitution, immunoprecipitation, co-immunoprecipitation, conformational antibody assay, cytochrome c release assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO/reconstitution experiments with multiple orthogonal readouts; independently extended by other labs","pmids":["12853473"],"is_preprint":false},{"year":2005,"finding":"ER-localized BIK activates a DRP1-dependent pathway that causes mitochondrial fragmentation and remodeling/opening of cristae (mobilizing intramitochondrial cytochrome c stores), distinct from DRP1's role in mitochondrial fission. BIK cooperates with the mitochondria-targeted BH3-only protein NOXA to activate BAX, causing rapid cytochrome c release and caspase activation, by a mechanism independent of DRP1 enzyme activity.","method":"Live cell imaging, selective digitonin permeabilization, dominant-negative DRP1, siRNA knockdown, co-expression experiments, cytochrome c localization","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods; functional dissection of DRP1 dependency; replicated in subsequent work","pmids":["15791210"],"is_preprint":false},{"year":2005,"finding":"ER-localized BIK regulates BAX/BAK-dependent Ca2+ release from ER stores upstream of effector caspase activation. BIK-induced Ca2+ release is abolished in BAX/BAK double-deficient cells but restored by ectopic BAK. p53 stimulates BAK recruitment to the ER, which is inhibited by BIK siRNA. DRP1 (Ca2+-regulated GTPase) is involved in p53-induced mitochondrial fission and cytochrome c release.","method":"siRNA knockdown, BAX/BAK double-KO cells, intracellular Ca2+ measurements, subcellular fractionation, dominant-negative constructs","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO plus siRNA plus Ca2+ imaging; consistent with parallel EMBO J 2005 paper","pmids":["15809295"],"is_preprint":false},{"year":2005,"finding":"Bortezomib stabilizes BIK protein from proteasomal degradation, leading to BIK accumulation that mediates apoptosis. BIK (and BIM) are required for bortezomib cytotoxicity; double-KO MEFs or cells with RNAi-mediated knockdown of both BIK and BIM are refractory to bortezomib. This establishes that BIK is normally degraded by the proteasome.","method":"Mouse embryo fibroblast double-KO, RNAi knockdown, Western blot, cell death assays","journal":"Molecular cancer therapeutics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO and siRNA in parallel; replicated across multiple cell lines and independently confirmed","pmids":["15767553"],"is_preprint":false},{"year":2007,"finding":"NBK/BIK activates BAK-dependent apoptosis in response to protein synthesis inhibition by antagonizing/displacing BAK from MCL-1 and BCL-XL sequestration. NBK/BIK-deficient and BAK-deficient cells are resistant to MazF toxin and pharmacologic translation inhibition. NBK/BIK functions as the apical regulator of a BAK-dependent apoptotic pathway specifically in response to shutoff of protein synthesis.","method":"Genetic KO cells, reconstitution, co-immunoprecipitation (displacement of BAK from MCL-1/BCL-XL), adenoviral inducible expression, pharmacological inhibitors","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple KO cell lines, reconstitution, and mechanistic Co-IP demonstrating displacement of BAK","pmids":["17403773"],"is_preprint":false},{"year":2007,"finding":"GRP78/BiP forms a complex with BIK at the ER. GRP78 overexpression decreases apoptosis induced by ER-targeted BIK and inhibits estrogen starvation-induced BAX activation and mitochondrial permeability transition. GRP78 interaction with BIK does not require the BH3 domain of BIK.","method":"Co-immunoprecipitation, siRNA knockdown, overexpression, apoptosis assays, domain deletion analysis","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, siRNA knockdown with functional rescue, domain mapping; single lab with multiple orthogonal methods","pmids":["17440086"],"is_preprint":false},{"year":2007,"finding":"BCL-2-null cells expressing BIK undergo caspase-independent cell death with autophagic features (cytosolic vacuoles, LC3 puncta, Beclin-1 upregulation, AIF nuclear redistribution) without cytochrome c release. This autophagic death is blocked by PI3K inhibitors (3-MA, wortmannin) or depletion of ATG5/Beclin-1.","method":"BCL-2 KO vs. WT MEFs, BIK overexpression, caspase inhibition, PI3K inhibitors, ATG5/Beclin-1 siRNA, electron microscopy, LC3 localization","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO background with multiple pharmacological and genetic interventions; single lab","pmids":["17873911"],"is_preprint":false},{"year":2007,"finding":"MCL-1 determines the BAX dependency of NBK/BIK-induced apoptosis. MCL-1 binding to BAK persists after NBK expression and prevents BAK activation in BAX-deficient cells. Targeted knockdown of MCL-1 allows BAK activation by NBK/BIK. In contrast, PUMA can disrupt MCL-1-BAK interaction and activate both BAX and BAK.","method":"siRNA knockdown of MCL-1, co-immunoprecipitation (MCL-1-BAK interaction), BAX/BAK-deficient cells, inducible BIK/NBK expression","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — mechanistic Co-IP plus genetic KO plus siRNA in single lab with multiple readouts","pmids":["18025305"],"is_preprint":false},{"year":2008,"finding":"BIK inhibits nuclear translocation of phospho-ERK1/2 to mediate IFN-gamma-induced cell death in airway epithelial cells. BIK (but not BikL61G mutant) physically interacts with and suppresses nuclear translocation of phospho-ERK1/2. Loss of BIK suppresses IFN-gamma-induced death and leads to persistence of hyperplastic epithelial cells.","method":"Bik KO mice, overexpression, BikL61G mutant, co-immunoprecipitation, immunofluorescence (phospho-ERK1/2 nuclear localization), in vivo allergen model","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — KO mouse model, mutagenesis showing L61G blocks interaction, reciprocal Co-IP, functional consequences in vivo","pmids":["18981230"],"is_preprint":false},{"year":2008,"finding":"RHBDD1, a rhomboid family serine protease, cleaves BIK at a site within its transmembrane region. RHBDD1 residues G142 and S144 are essential for this proteolytic activity. RHBDD1 overexpression reduces BIK-mediated apoptosis; RHBDD1 knockdown enhances it. This cleavage is upstream of BIK protein degradation.","method":"Site-directed mutagenesis of RHBDD1, overexpression and siRNA knockdown, Western blot for BIK cleavage, apoptosis assays","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis of catalytic residues plus functional KD/OE; single lab","pmids":["18953687"],"is_preprint":false},{"year":2009,"finding":"TGF-beta induces BIK transcription in human B cells via direct Smad binding to a consensus Smad-binding element in the BIK promoter, and simultaneously represses BCL-XL. BIK induction is required for TGF-beta-induced apoptosis; shRNA suppression of BIK diminishes it.","method":"Chromatin immunoprecipitation (ChIP) for Smad binding at BIK promoter, promoter reporter assay, shRNA knockdown, overexpression","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct Smad binding plus functional reporter and shRNA; single lab, multiple orthogonal methods","pmids":["19136942"],"is_preprint":false},{"year":2011,"finding":"GRP78 forms a complex with BIK independent of the BH3 domain and competes with BCL-2 for BIK binding. Increased GRP78 expression decreases BIK-BCL-2 complex formation, thereby releasing BCL-2 from BIK sequestration. This mechanism confers endocrine resistance in breast cancer cells.","method":"Co-immunoprecipitation, BH3 deletion mutants, overexpression/knockdown, apoptosis assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — domain mapping with BH3 deletion, competitive Co-IP showing GRP78 displaces BCL-2 from BIK; single lab with multiple orthogonal methods","pmids":["21622563"],"is_preprint":false},{"year":2012,"finding":"BIK mRNA 3' end processing and expression are controlled by the nuclear poly(A) polymerase Star-PAP downstream of DNA damage signals. PKCdelta associates with the Star-PAP complex and is required for BIK expression. PIPKIalpha generates PI4,5P2 that directly stimulates PKCdelta activity in the Star-PAP complex. Features in the BIK 3' UTR define Star-PAP specificity and may block canonical PAP activity.","method":"siRNA/shRNA knockdown, co-immunoprecipitation, kinase assays, 3' end processing assays, reporter assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic pathway with multiple Co-IPs, kinase assays, and functional 3' processing assays in single rigorous study","pmids":["22244330"],"is_preprint":false},{"year":2012,"finding":"Src tyrosine kinase inhibits apoptosis by increasing BIK degradation via activation of the Ras-Raf-MEK1/2-ERK1/2 pathway. ERK1/2 phosphorylates BIK on Thr124, which drives BIK ubiquitylation on Lys33 and subsequent proteasomal degradation.","method":"Phosphorylation site mapping by mutagenesis, ubiquitylation assays, proteasome inhibitor, ERK1/2 pathway inhibitors, v-Src transformed fibroblasts","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1 / Moderate — phosphorylation and ubiquitylation site mapping by mutagenesis with functional consequence; single lab, multiple orthogonal methods","pmids":["22388352"],"is_preprint":false},{"year":2014,"finding":"Disruption of SQSTM1/p62 causes cargo loading failure and accumulation of NBK/Bik on ER membranes (by blocking autophagic degradation of NBK/Bik), leading to apoptosis. NBK/Bik knockdown markedly attenuates apoptosis caused by SQSTM1/p62 targeting. Autophagy initiation inhibitors (Ulk1, Beclin-1, Atg5 shRNA) substantially diminish NBK/Bik accumulation, while distal autophagy blockade enhances it.","method":"shRNA knockdown, co-immunoprecipitation, Western blot for ER-associated BIK, genetic/pharmacologic autophagy inhibition, in vivo xenograft","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic knockdowns and pharmacologic tools; single lab","pmids":["25002530"],"is_preprint":false},{"year":2017,"finding":"BIK dissociates the BAK/BCL-2 complex to enrich for ER-associated BAK and interacts with the kinase domain of DAPk1, forming a BIK-DAPk1-ERK1/2-BAK complex. BIK disrupts the BCL-2-IP3R interaction to cause ER Ca2+ release. ER-associated BAK (enriched by BIK) interacts with DAPk1 calmodulin domain to increase ER-mitochondria contact sites and facilitate mitochondrial Ca2+ uptake. The BIK BH3 helix is sufficient for ER-BAK enrichment and ER Ca2+ release, but mitochondrial Ca2+ uptake also requires BAK.","method":"Co-immunoprecipitation, siRNA knockdown, domain deletion analysis, Ca2+ imaging, ER-mitochondria contact site quantification, BIK peptide experiments, mouse allergen model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple Co-IPs, domain mapping, Ca2+ imaging, mouse in vivo model; comprehensive mechanistic study","pmids":["28986568"],"is_preprint":false},{"year":2017,"finding":"p53 promotes apoptosis during prolonged ER stress by suppressing BiP/GRP78 expression via binding to the first 346-nt of the bip mRNA through a trans-suppression domain in the first 7 N-terminal amino acids of p53ΔN40. BiP suppression releases pro-apoptotic BIK from BiP, activating apoptosis.","method":"BiP mRNA binding assays, reporter assays, p53 isoform overexpression, siRNA knockdown, apoptosis assays","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mRNA binding assay, reporter assay, and functional siRNA; single lab","pmids":["28622297"],"is_preprint":false},{"year":2019,"finding":"Cul5-ASB11 is the E3 ubiquitin ligase that targets BIK for ubiquitination and proteasomal degradation. During ER stress, XBP1s (activated by IRE1alpha) activates ASB11, which stimulates BIK ubiquitination, interaction with p97/VCP, and proteolysis, promoting cell survival during the adaptive phase. Genotoxic agents downregulate the IRE1alpha-XBP1s-ASB11 axis to stabilize BIK and promote apoptosis.","method":"Co-immunoprecipitation, ubiquitination assays, ASB11 siRNA/overexpression, IRE1alpha inhibitor, XBP1s overexpression, in vivo tumor model","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic Co-IP identifying E3 ligase, ubiquitination assays, pathway validation with multiple genetic/pharmacologic tools","pmids":["31387940"],"is_preprint":false},{"year":2021,"finding":"Casein kinase IIalpha (CKIIalpha) is responsible for phosphorylating BIK at Thr33/Ser35 to activate it. CKIIalpha is expressed only during G2/M phase, causing BIK to selectively kill proliferating (S/G2/M) cells. BIK phosphorylation mutants at Thr33 or Ser35 demonstrated that phosphorylation activates BIK to induce death even in quiescent cells. BIK protein is detectable only in green (S/G2/M) cells using fluorescent ubiquitin cell cycle indicators.","method":"Fluorescent ubiquitin cell cycle indicators (FUCCI), co-immunoprecipitation, proteomics, phosphorylation site mutagenesis, CKIIalpha siRNA, airway epithelial cell cultures and mouse model","journal":"Journal of cellular physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — kinase identified by proteomics/Co-IP, confirmed by mutagenesis of phosphorylation sites with functional consequence; FUCCI cell cycle tracking","pmids":["34741311"],"is_preprint":false},{"year":2023,"finding":"BIK, although predominantly ER-localized, can directly bind mitochondria-localized BCL-XL and BCL-2 via its BH3 region (detected by FLIM-FRET). In BMK-BAX/BAK DKO cells, a fraction of BIK moves toward mitochondria in response to mitochondria-localized BCL-XL. In MCF-7 cells, BIK is also present at mitochondria-associated ER membranes and binds mitochondria-localized BCL-XL via relocalization. This suggests BIK initiates mitochondrial outer membrane permeabilization via direct interactions at ER-mitochondria contact sites.","method":"FLIM-FRET microscopy, BH3 mutagenesis, BAX/BAK DKO cells, mitochondria-targeted BCL-XL chimeric mutants, subcellular localization imaging","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — FLIM-FRET for direct binding detection, BH3 mutagenesis as control, BAX/BAK DKO cells; rigorous single study","pmids":["36603764"],"is_preprint":false},{"year":2023,"finding":"BIK deficiency causes low-grade inflammation and spontaneous emphysema in female but not male mice. Mechanistically, BIK modifies the BH4 domain of BCL-2 to interact with proteasome regulatory particles RPN1 and RPN2, enhancing proteasomal degradation of nuclear proteins (including nuclear p65). BCL-2 and BIK levels are lower in female vs. male mouse lung, explaining the sex-specific phenotype.","method":"Bik KO mouse model, transgenic airway BIK overexpression, co-immunoprecipitation (BIK-BCL-2, BIK-RPN1/RPN2), proteasomal degradation assays, nuclear/cytosolic fractionation, LPS/allergen models","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO and transgenic mouse models, mechanistic Co-IP identifying novel proteasome interaction via BCL-2 BH4 domain, multiple orthogonal readouts","pmids":["38113109"],"is_preprint":false},{"year":2023,"finding":"TMEM215 forms a complex with BiP/GRP78, which in turn interacts with BIK. TMEM215 knockdown triggers BIK-dependent apoptosis in endothelial cells via increased mitochondria-associated ER membrane contacts and mitochondrial Ca2+ influx through IP3R and MCU. Inhibiting IP3R or MCU abrogates TMEM215 knockdown-induced apoptosis.","method":"Co-immunoprecipitation-mass spectrometry, siRNA knockdown, BIK siRNA rescue, Ca2+ imaging, IP3R/MCU inhibitors, EC-specific Tmem215 KO mouse","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — proteomic identification of complex, multiple genetic/pharmacologic validations, KO mouse model with in vivo phenotype","pmids":["37750320"],"is_preprint":false},{"year":2014,"finding":"HCV NS5B RNA polymerase induces BIK expression and co-localizes and interacts with BIK by co-immunoprecipitation, suggesting BIK interacts with the HCV replication complex. BIK is required for efficient HCV RNA replication and viral release; BIK-depleted cells show significantly reduced viral replication.","method":"Co-immunoprecipitation, immunofluorescence co-localization, siRNA knockdown, viral titer assays, BIK overexpression","journal":"Virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and co-localization plus functional KD; single lab, mechanistic follow-up limited","pmids":["25463603"],"is_preprint":false},{"year":2016,"finding":"BIK mediates caspase-dependent cleavage of influenza A virus (IAV) nucleoprotein (NP) and M2 proteins, and enables cytoplasmic export of viral ribonucleoprotein. Bik-deficient mouse AECs show attenuated IAV replication, reduced caspase-3 activation, and impaired viral NP/M2 cleavage. Bik-deficient mice are protected from IAV lethality.","method":"Bik KO mouse model, siRNA knockdown in human AECs, viral titer assays, Western blot for viral protein cleavage, caspase-3 activation, viral RNP nuclear export assays","journal":"American journal of respiratory cell and molecular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mouse model in vivo, siRNA in human cells, mechanistic dissection of viral protein cleavage; replicated in subsequent papers","pmids":["26437021"],"is_preprint":false},{"year":2025,"finding":"IAV nucleoprotein (NP) suppresses the β5 subunit of the proteasome, leading to BIK accumulation and enhanced viral replication. BIK interacts with NP, disrupting the BCL-2/NP interaction and promoting viral replication. β5 treatment dampens BIK levels and protects mice from IAV-induced morbidity. A BIK promoter SNP (rs738276) influences BIK expression and correlates with influenza severity.","method":"Co-immunoprecipitation (BIK-NP, BCL-2-NP), β5 subunit knockdown/treatment, BIK KO/overexpression mouse model, air-liquid interface primary cell cultures, human cohort genotyping","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic Co-IP identifying BIK-NP interaction, proteasome subunit manipulation, KO and transgenic mouse models, human cohort validation","pmids":["40627391"],"is_preprint":false},{"year":2017,"finding":"TMEM74, a lysosome transmembrane protein, interacts with BIK via its transmembrane (TM) domains and the BH3 domain of BIK. TMEM74 co-localizes with BIK in subcellular organelles and inhibits BIK-induced apoptosis. TM domain-deficient TMEM74 mutant loses this inhibitory function.","method":"Co-immunoprecipitation, fluorescent co-localization, domain deletion analysis, apoptosis assays, knockdown","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP with domain mapping; single lab, functional consequence demonstrated","pmids":["28412412"],"is_preprint":false},{"year":2006,"finding":"BIK mRNA levels are induced by fulvestrant via a p53-dependent but non-transcriptional mechanism (p53 transcriptional activity is not required, unlike for PUMA induction by doxorubicin). BIK protein is subject to rapid proteasomal degradation in some breast cancer cell lines.","method":"siRNA knockdown of p53, dominant-negative p53, reporter assay, BIK mRNA stability assay, proteasome inhibitor MG132, Western blot","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic approaches with functional readouts; single lab","pmids":["17047080"],"is_preprint":false},{"year":2006,"finding":"E2F transcription factors directly activate the BIK promoter, contributing to chemotherapy-induced BIK expression in cancer cells by a p53-independent mechanism. E2F-mediated BIK induction is required for efficient adriamycin-induced apoptosis.","method":"Promoter-reporter assays, ChIP, E2F overexpression and knockdown, apoptosis assays","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay demonstrating direct E2F binding; single lab","pmids":["17027756"],"is_preprint":false},{"year":2009,"finding":"PAR bZIP transcription factors (TEF, DBP) directly activate the BIK promoter. In PAR bZIP triple-KO fibroblasts, bik is the only BH3-only gene downregulated. PAR bZIP proteins mediate oxidative stress (H2O2)-induced apoptosis through BIK, as confirmed by BIK knockdown rescue experiments.","method":"PAR bZIP triple-KO mouse fibroblasts, promoter-reporter assay, ChIP, BIK siRNA rescue, oxidative stress apoptosis assays","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP, KO fibroblasts, functional rescue by siRNA; single lab","pmids":["19219069"],"is_preprint":false},{"year":2003,"finding":"BIK antitumor activity in vivo requires an intact BH3 domain. BH3 domain deletion abolishes cytochrome c release, caspase (9, 7, 3) activation, and tumor growth suppression in xenograft models.","method":"Adenoviral overexpression, BH3 deletion mutant, cytochrome c release assay, caspase activity, nude mouse xenograft","journal":"Molecular cancer therapeutics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean mutagenesis with both in vitro and in vivo functional validation; single lab","pmids":["12467227"],"is_preprint":false},{"year":2005,"finding":"Bik and Bim show functional redundancy in eliminating supernumerary spermatogonia and spermatocytes during the first wave of spermatogenesis. Bik single-KO mice are fertile, but bik-/-bim-/- double-KO adult males are infertile with arrested spermatogenesis and increased early germ cells—a phenotype similar to Bax deficiency, placing Bik and Bim upstream of Bax.","method":"Bik-KO, Bim-KO, and Bik/Bim double-KO mouse generation, histology, fertility assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean double-KO mouse genetics demonstrating synthetic phenotype, epistasis with Bax","pmids":["16270031"],"is_preprint":false}],"current_model":"BIK is a BH3-only pro-apoptotic protein predominantly residing in the endoplasmic reticulum membrane via its C-terminal transmembrane domain, where it initiates apoptosis by (1) releasing Ca2+ from ER stores in a BAX/BAK-dependent manner through disruption of BCL-2-IP3R interaction and enrichment of ER-associated BAK via a DAPk1 complex, (2) triggering DRP1-dependent mitochondrial cristae remodeling and cytochrome c mobilization, (3) directly binding anti-apoptotic proteins (BCL-2, BCL-XL, MCL-1) via its BH3 domain at ER-mitochondria contact sites to displace and activate BAX/BAK, (4) acting as a 'sensitizer' BH3-only protein that cooperates with effector BH3-only proteins (e.g., NOXA) for rapid cytochrome c release; its pro-apoptotic activity is governed by phosphorylation at Thr33/Ser35 by casein kinase IIalpha (active in G2/M), ubiquitination on Lys33 by Cul5-ASB11 E3 ligase targeting it for proteasomal degradation (regulated by the IRE1alpha-XBP1s axis during ER stress or by ERK1/2-phosphorylation of Thr124 downstream of oncogenic signaling), and inhibitory interaction with GRP78/BiP; additionally, BIK modifies BCL-2's BH4 domain to interact with proteasome subunits RPN1/RPN2 to promote degradation of nuclear proteins including NF-kB p65, thereby suppressing low-grade inflammation."},"narrative":{"mechanistic_narrative":"BIK (NBK) is a BH3-only pro-apoptotic member of the BCL-2 family that initiates the intrinsic apoptotic pathway from the endoplasmic reticulum, where it resides via a C-terminal transmembrane anchor [PMID:8816500, PMID:11884414, PMID:11971188]. It was originally identified by its capacity to bind anti-apoptotic proteins BCL-2, BCL-XL, and viral homologs (EBV-BHRF1, adenovirus E1B-19K) through a conserved BH3 domain, the death-promoting activity of which is neutralized by these survival proteins [PMID:7478623, PMID:8816500]. Structure-function dissection established the BH3 region (residues 57–74) as the heterodimerization interface, while additional C-terminal sequences are required for efficient killing [PMID:9305912, PMID:12467227]. Rather than directly engaging effectors, BIK acts largely as a 'sensitizer': it does not bind BAX directly but displaces effectors such as BAK from MCL-1 and BCL-XL sequestration, and the resulting activation of BAX or BAK depends on cellular MCL-1 levels [PMID:12853473, PMID:17403773, PMID:18025305]. From its ER station, BIK drives BAX/BAK-dependent Ca2+ release from ER stores and a DRP1-dependent remodeling of mitochondrial cristae that mobilizes cytochrome c, cooperating with mitochondrial BH3 proteins like NOXA for rapid cytochrome c release [PMID:15791210, PMID:15809295]; it can also relocalize to ER–mitochondria contact sites to directly bind mitochondrial BCL-XL/BCL-2 via its BH3 helix and assembles a BIK–DAPk1–ERK1/2–BAK complex that enriches ER-associated BAK and disrupts BCL-2–IP3R interaction to gate Ca2+ flux [PMID:28986568, PMID:36603764]. BIK is transcriptionally induced by diverse death stimuli—via E2F and p53 during genotoxic and oncogene stress, by TGF-beta/Smad and PAR bZIP factors, and through Star-PAP-dependent 3' end processing after DNA damage [PMID:11971188, PMID:19136942, PMID:22244330, PMID:17027756, PMID:19219069]. Its activity is tightly restrained post-translationally: CKIIalpha phosphorylation at Thr33/Ser35 activates BIK in a cell-cycle-restricted manner, ERK1/2 phosphorylation at Thr124 promotes Lys33 ubiquitination, and the Cul5-ASB11 E3 ligase (regulated by the IRE1alpha-XBP1s axis) targets BIK for proteasomal degradation, while GRP78/BiP sequesters BIK at the ER independent of its BH3 domain [PMID:11084041, PMID:22388352, PMID:31387940, PMID:34741311, PMID:21622563, PMID:17440086]. Genetic evidence places BIK in physiological apoptosis—redundant with BIM upstream of BAX in spermatogenesis [PMID:16270031]—and in IFN-gamma-driven clearance of airway epithelium and suppression of low-grade inflammation, the latter through a non-apoptotic role modifying the BCL-2 BH4 domain to recruit proteasome subunits RPN1/RPN2 for degradation of nuclear p65 [PMID:18981230, PMID:38113109]. BIK is also co-opted by viruses, being required for efficient HCV and influenza A virus replication [PMID:25463603, PMID:26437021, PMID:40627391].","teleology":[{"year":1995,"claim":"Established BIK as a pro-apoptotic protein defined by a BH3 domain that physically engages anti-apoptotic BCL-2 family and viral survival proteins, framing it as a counter-regulator of cell survival machinery.","evidence":"Co-IP, yeast two-hybrid, and transient transfection apoptosis assays identifying BCL-2/BCL-XL/BHRF1/E1B-19K binding","pmids":["7478623","8816500"],"confidence":"High","gaps":["Did not resolve whether BIK acts directly on effectors or only sequesters anti-apoptotic proteins","Subcellular site of action undefined"]},{"year":1997,"claim":"Defined the BH3 (57–74) as the heterodimerization core but showed heterodimerization alone is insufficient for killing, implicating additional C-terminal determinants and positioning BIK in the mid-stream caspase cascade.","evidence":"Deletion mutagenesis with functional apoptosis assays; CrmA/IAP epistasis","pmids":["9305912","9082997"],"confidence":"High","gaps":["Molecular function of the C-terminal requirement not defined","Epistasis placement based on single-method overexpression"]},{"year":2000,"claim":"Identified BIK as a phosphoprotein whose apoptotic activity requires CKII-like phosphorylation at Thr33/Ser35, separating its killing function from its heterodimerization activity.","evidence":"Metabolic 32P labeling, phosphosite mutagenesis (T33A/S35A), partial kinase purification; genomic/promoter characterization","pmids":["11084041","10974546"],"confidence":"High","gaps":["Kinase identity not definitively established at this stage","How phosphorylation activates BIK mechanistically unknown"]},{"year":2002,"claim":"Localized BIK action to the ER membrane and demonstrated it triggers mitochondrial cytochrome c release in a BH3-dependent, distance-acting manner; linked BIK induction to the E1A/p53 axis.","evidence":"Subcellular fractionation, membrane-anchor swap, in vitro reconstitution; microarray/RT-PCR for p53-dependent induction","pmids":["11884414","11971188"],"confidence":"High","gaps":["The diffusible signal from ER to mitochondria not identified","Effector dependency (BAX vs BAK) not resolved"]},{"year":2003,"claim":"Showed BIK acts as a sensitizer requiring BAX—not directly binding it but driving its conformational activation—and confirmed BH3-dependent antitumor activity in vivo.","evidence":"BAX-KO/reconstitution, conformational antibody and cytochrome c assays, Co-IP; xenograft with BH3 deletion mutant","pmids":["12853473","12467227"],"confidence":"High","gaps":["Why BAK is dispensable in these settings unresolved","Identity of the effector-activating intermediary unknown"]},{"year":2005,"claim":"Resolved the ER-to-mitochondria mechanism: BIK drives BAX/BAK-dependent ER Ca2+ release and a DRP1-dependent cristae remodeling that mobilizes cytochrome c, cooperating with NOXA for rapid release.","evidence":"Live-cell imaging, BAX/BAK DKO cells, dominant-negative/siRNA DRP1, Ca2+ imaging, selective permeabilization","pmids":["15791210","15809295"],"confidence":"High","gaps":["How DRP1-independent cristae opening is mechanically achieved unclear","Direct molecular link between Ca2+ release and effector activation incomplete"]},{"year":2005,"claim":"Demonstrated BIK is constitutively degraded by the proteasome and that proteasome inhibition (bortezomib) requires BIK for cytotoxicity, establishing protein stability as a key activity switch.","evidence":"BIK/BIM double-KO MEFs, RNAi, Western blot, cell death assays; in vivo spermatogenesis double-KO genetics","pmids":["15767553","16270031"],"confidence":"High","gaps":["E3 ligase responsible not yet identified","Functional redundancy with BIM limits single-gene phenotype interpretation"]},{"year":2007,"claim":"Defined how anti-apoptotic context dictates effector choice: BIK displaces BAK from MCL-1/BCL-XL, and MCL-1 levels determine whether BIK kills via BAX or BAK, particularly in response to translation shutoff.","evidence":"Genetic KO/reconstitution, displacement Co-IP, MCL-1 siRNA, BAX/BAK-deficient cells","pmids":["17403773","18025305"],"confidence":"High","gaps":["Quantitative affinity hierarchy of BIK for different anti-apoptotic proteins not measured","Stimulus specificity for translation inhibition mechanistically incomplete"]},{"year":2007,"claim":"Identified GRP78/BiP as a BH3-independent ER inhibitor of BIK and revealed a caspase-independent autophagic death program activated by BIK in BCL-2-null cells.","evidence":"Reciprocal Co-IP, domain mapping, siRNA rescue; BCL-2 KO MEFs with PI3K/ATG5/Beclin-1 interventions and EM","pmids":["17440086","17873911"],"confidence":"High","gaps":["Mechanism linking BIK to autophagy machinery undefined","Autophagic-death finding is Medium confidence, single lab"]},{"year":2008,"claim":"Uncovered post-translational and proteolytic regulation: RHBDD1 cleaves BIK within its TM region, and BIK suppresses nuclear translocation of phospho-ERK1/2 to drive IFN-gamma-induced epithelial death in vivo.","evidence":"RHBDD1 catalytic-residue mutagenesis and KD/OE; Bik-KO mice, BikL61G mutant, Co-IP, immunofluorescence, allergen model","pmids":["18953687","18981230"],"confidence":"High","gaps":["RHBDD1 cleavage finding Medium confidence, single lab","How a membrane-anchored BIK influences nuclear ERK trafficking is mechanistically unclear"]},{"year":2009,"claim":"Mapped transcriptional control of BIK to stimulus-specific factors: TGF-beta/Smad directly induces BIK while repressing BCL-XL, and PAR bZIP factors mediate oxidative-stress-induced apoptosis through BIK.","evidence":"ChIP, promoter reporters, shRNA/siRNA rescue; PAR bZIP triple-KO fibroblasts","pmids":["19136942","19219069"],"confidence":"Medium","gaps":["Integration of multiple transcriptional inputs not reconciled","PAR bZIP work single lab, Medium confidence"]},{"year":2012,"claim":"Revealed two distinct regulatory layers: Star-PAP/PKCdelta/PIPKIalpha controls BIK mRNA 3' processing after DNA damage, and Src-Ras-ERK1/2 phosphorylation of Thr124 drives Lys33 ubiquitylation and degradation downstream of oncogenic signaling.","evidence":"siRNA, Co-IP, kinase and 3'-processing assays; phospho/ubiquitin site mapping in v-Src fibroblasts with proteasome and ERK inhibitors","pmids":["22244330","22388352"],"confidence":"High","gaps":["E3 ligase acting downstream of Thr124 phosphorylation not identified here","Cross-talk between transcriptional and degradative control undefined"]},{"year":2014,"claim":"Linked autophagy and an alternative GRP78 mechanism to BIK levels: SQSTM1/p62-mediated autophagy clears ER-associated BIK, and GRP78 competes with BCL-2 for BIK to confer endocrine resistance.","evidence":"shRNA, Co-IP, autophagy inhibitors, xenograft; competitive Co-IP with BH3-deletion mutants","pmids":["25002530","21622563"],"confidence":"Medium","gaps":["Relative contributions of autophagic vs proteasomal turnover not quantified","p62 finding Medium confidence, single lab"]},{"year":2017,"claim":"Built a spatial model of BIK action at ER–mitochondria junctions: BIK assembles a BIK–DAPk1–ERK1/2–BAK complex, enriches ER-associated BAK, disrupts BCL-2–IP3R to release ER Ca2+, and connects p53 suppression of BiP to BIK release during ER stress.","evidence":"Co-IP, domain mapping, Ca2+ imaging, contact-site quantification, BIK peptides, allergen model; BiP mRNA binding/reporter assays for p53","pmids":["28986568","28622297"],"confidence":"High","gaps":["Stoichiometry and assembly order of the BIK–DAPk1–BAK complex undefined","p53/BiP arm is Medium confidence"]},{"year":2019,"claim":"Identified Cul5-ASB11 as the E3 ligase for BIK and integrated it into the ER-stress response: IRE1alpha-XBP1s activates ASB11 to degrade BIK during adaptive survival, while genotoxic stress downregulates this axis to stabilize BIK.","evidence":"Co-IP, ubiquitination assays, ASB11/IRE1alpha manipulation, XBP1s overexpression, in vivo tumor model","pmids":["31387940"],"confidence":"High","gaps":["How ASB11 substrate recognition is regulated unknown","Relationship to Thr124-phosphorylation degradation pathway not reconciled"]},{"year":2021,"claim":"Identified CKIIalpha as the activating kinase for BIK Thr33/Ser35 and showed its G2/M-restricted expression renders BIK a selective killer of proliferating cells.","evidence":"FUCCI cell-cycle tracking, proteomics/Co-IP, phosphosite mutagenesis, CKIIalpha siRNA, airway cells and mouse model","pmids":["34741311"],"confidence":"High","gaps":["Structural basis for phospho-activation not solved","Interplay with degradative phosphorylation events undefined"]},{"year":2023,"claim":"Established direct BIK–anti-apoptotic binding at mitochondria/ER-mitochondria contacts and uncovered a non-apoptotic role in which BIK directs BCL-2 BH4-mediated proteasomal degradation of nuclear p65 to suppress inflammation.","evidence":"FLIM-FRET, BH3 mutagenesis, BAX/BAK DKO and mito-targeted BCL-XL chimeras; Bik KO/transgenic mice, BIK-BCL-2/RPN1/RPN2 Co-IP, fractionation","pmids":["36603764","38113109"],"confidence":"High","gaps":["How BIK toggles between pro-apoptotic and proteasome-recruiting modes unclear","Basis of sex-specific BIK/BCL-2 expression not fully explained"]},{"year":2023,"claim":"Connected BIK to ER-membrane sensing complexes, showing TMEM215-GRP78-BIK assemblies gate endothelial apoptosis via MAM Ca2+ flux through IP3R and MCU.","evidence":"Co-IP-MS, siRNA with BIK rescue, Ca2+ imaging, IP3R/MCU inhibitors, EC-specific Tmem215 KO mouse","pmids":["37750320"],"confidence":"High","gaps":["How TMEM215 loss liberates BIK from GRP78 mechanistically undefined","Tissue specificity of this complex unexplored"]},{"year":2025,"claim":"Defined a viral exploitation axis: influenza A and HCV co-opt BIK for replication, with IAV NP suppressing the proteasome to accumulate BIK and disrupting BCL-2/NP interactions, and a BIK promoter SNP correlating with influenza severity.","evidence":"Co-IP (BIK-NP, BCL-2-NP), proteasome subunit manipulation, BIK KO/transgenic mice, primary cultures, human cohort genotyping; earlier HCV NS5B and IAV NP/M2 cleavage studies","pmids":["40627391","26437021","25463603"],"confidence":"High","gaps":["Mechanism by which a pro-apoptotic protein aids viral replication not fully resolved","HCV interaction is Medium confidence"]},{"year":null,"claim":"How BIK's molecular state is switched between its canonical pro-apoptotic effector-sensitizing function and its non-apoptotic proteasome-directing role, and how the competing activating phosphorylation, degradative phosphorylation/ubiquitination, and chaperone-sequestration inputs are integrated to set a death threshold, remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No structural model of activated BIK at ER-mitochondria contacts","Quantitative integration of opposing regulatory inputs not established","Mechanistic basis for BIK promoting viral replication unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,2,8,12,15]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[8,12,15]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,6,7,13]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[27]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,1,6,8,37]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[10,23,25]}],"complexes":["BIK-DAPk1-ERK1/2-BAK complex","TMEM215-GRP78-BIK complex"],"partners":["BCL2","BCL2L1","MCL1","BAK1","HSPA5","DAPK1","ASB11","TMEM215"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q13323","full_name":"Bcl-2-interacting killer","aliases":["Apoptosis inducer NBK","BIP1","BP4"],"length_aa":160,"mass_kda":18.0,"function":"Accelerates programmed cell death. Association to the apoptosis repressors Bcl-X(L), BHRF1, Bcl-2 or its adenovirus homolog E1B 19k protein suppresses this death-promoting activity. Does not interact with BAX","subcellular_location":"Endomembrane system; Mitochondrion membrane","url":"https://www.uniprot.org/uniprotkb/Q13323/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BIK","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BIK","total_profiled":1310},"omim":[{"mim_id":"621029","title":"RING FINGER PROTEIN 183; RNF183","url":"https://www.omim.org/entry/621029"},{"mim_id":"619478","title":"FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 4, DIGENIC; FSHD4","url":"https://www.omim.org/entry/619478"},{"mim_id":"614350","title":"LYNCH SYNDROME 5; LYNCH5","url":"https://www.omim.org/entry/614350"},{"mim_id":"606266","title":"BCL2-MODIFYING FACTOR; BMF","url":"https://www.omim.org/entry/606266"},{"mim_id":"606009","title":"DOUBLE HOMEOBOX PROTEIN 4; DUX4","url":"https://www.omim.org/entry/606009"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"salivary gland","ntpm":16.9}],"url":"https://www.proteinatlas.org/search/BIK"},"hgnc":{"alias_symbol":["NBK"],"prev_symbol":[]},"alphafold":{"accession":"Q13323","domains":[{"cath_id":"1.20.5","chopping":"52-87","consensus_level":"medium","plddt":70.4175,"start":52,"end":87},{"cath_id":"1.10.287","chopping":"90-158","consensus_level":"high","plddt":72.3328,"start":90,"end":158}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13323","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13323-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13323-F1-predicted_aligned_error_v6.png","plddt_mean":62.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BIK","jax_strain_url":"https://www.jax.org/strain/search?query=BIK"},"sequence":{"accession":"Q13323","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13323.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13323/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13323"}},"corpus_meta":[{"pmid":"7478623","id":"PMC_7478623","title":"Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins.","date":"1995","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/7478623","citation_count":408,"is_preprint":false},{"pmid":"15791210","id":"PMC_15791210","title":"Endoplasmic reticulum BIK initiates DRP1-regulated remodelling of mitochondrial cristae during apoptosis.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15791210","citation_count":284,"is_preprint":false},{"pmid":"17440086","id":"PMC_17440086","title":"GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17440086","citation_count":264,"is_preprint":false},{"pmid":"8816500","id":"PMC_8816500","title":"Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8816500","citation_count":168,"is_preprint":false},{"pmid":"15767553","id":"PMC_15767553","title":"The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim.","date":"2005","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/15767553","citation_count":150,"is_preprint":false},{"pmid":"15809295","id":"PMC_15809295","title":"BH3-only BIK regulates BAX,BAK-dependent release of Ca2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15809295","citation_count":149,"is_preprint":false},{"pmid":"27845892","id":"PMC_27845892","title":"LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27845892","citation_count":125,"is_preprint":false},{"pmid":"11884414","id":"PMC_11884414","title":"BH-3-only BIK functions at the endoplasmic reticulum to stimulate cytochrome c release from mitochondria.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11884414","citation_count":123,"is_preprint":false},{"pmid":"17403773","id":"PMC_17403773","title":"NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition.","date":"2007","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/17403773","citation_count":113,"is_preprint":false},{"pmid":"21622563","id":"PMC_21622563","title":"Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK).","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21622563","citation_count":113,"is_preprint":false},{"pmid":"15824729","id":"PMC_15824729","title":"Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15824729","citation_count":109,"is_preprint":false},{"pmid":"11971188","id":"PMC_11971188","title":"Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11971188","citation_count":107,"is_preprint":false},{"pmid":"12853473","id":"PMC_12853473","title":"Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12853473","citation_count":107,"is_preprint":false},{"pmid":"19641504","id":"PMC_19641504","title":"BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes.","date":"2008","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19641504","citation_count":103,"is_preprint":false},{"pmid":"14749373","id":"PMC_14749373","title":"Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14749373","citation_count":99,"is_preprint":false},{"pmid":"16322756","id":"PMC_16322756","title":"Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma.","date":"2006","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/16322756","citation_count":86,"is_preprint":false},{"pmid":"16270031","id":"PMC_16270031","title":"Concomitant loss of proapoptotic BH3-only Bcl-2 antagonists Bik and Bim arrests spermatogenesis.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16270031","citation_count":85,"is_preprint":false},{"pmid":"19136942","id":"PMC_19136942","title":"TGF-beta induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-XL.","date":"2009","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/19136942","citation_count":77,"is_preprint":false},{"pmid":"11084041","id":"PMC_11084041","title":"Phosphorylation of the pro-apoptotic protein BIK: mapping of phosphorylation sites and effect on apoptosis.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11084041","citation_count":74,"is_preprint":false},{"pmid":"14983013","id":"PMC_14983013","title":"The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14983013","citation_count":72,"is_preprint":false},{"pmid":"25002530","id":"PMC_25002530","title":"Targeting SQSTM1/p62 induces cargo loading failure and converts autophagy to apoptosis via NBK/Bik.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25002530","citation_count":68,"is_preprint":false},{"pmid":"22244330","id":"PMC_22244330","title":"Star-PAP control of BIK expression and apoptosis is regulated by nuclear PIPKIα and PKCδ signaling.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22244330","citation_count":68,"is_preprint":false},{"pmid":"11782349","id":"PMC_11782349","title":"Systemic tumor suppression by the proapoptotic gene bik.","date":"2002","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11782349","citation_count":65,"is_preprint":false},{"pmid":"18566236","id":"PMC_18566236","title":"Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells.","date":"2008","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/18566236","citation_count":62,"is_preprint":false},{"pmid":"17873911","id":"PMC_17873911","title":"BH3-only protein BIK induces caspase-independent cell death with autophagic features in Bcl-2 null cells.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17873911","citation_count":57,"is_preprint":false},{"pmid":"9305912","id":"PMC_9305912","title":"Functional dissection of the pro-apoptotic protein Bik. Heterodimerization with anti-apoptosis proteins is insufficient for induction of cell death.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9305912","citation_count":54,"is_preprint":false},{"pmid":"16082182","id":"PMC_16082182","title":"Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation.","date":"2005","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/16082182","citation_count":53,"is_preprint":false},{"pmid":"9082997","id":"PMC_9082997","title":"Bik and Bak induce apoptosis downstream of CrmA but upstream of inhibitor of apoptosis.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9082997","citation_count":51,"is_preprint":false},{"pmid":"11803466","id":"PMC_11803466","title":"The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11803466","citation_count":50,"is_preprint":false},{"pmid":"30176890","id":"PMC_30176890","title":"KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer.","date":"2018","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/30176890","citation_count":49,"is_preprint":false},{"pmid":"18953687","id":"PMC_18953687","title":"A novel member of the Rhomboid family, RHBDD1, regulates BIK-mediated apoptosis.","date":"2008","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/18953687","citation_count":49,"is_preprint":false},{"pmid":"22388352","id":"PMC_22388352","title":"Src tyrosine kinase inhibits apoptosis through the Erk1/2- dependent degradation of the death accelerator Bik.","date":"2012","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/22388352","citation_count":49,"is_preprint":false},{"pmid":"17047080","id":"PMC_17047080","title":"Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17047080","citation_count":48,"is_preprint":false},{"pmid":"28622297","id":"PMC_28622297","title":"p53-mediated suppression of BiP triggers BIK-induced apoptosis during prolonged endoplasmic reticulum stress.","date":"2017","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/28622297","citation_count":48,"is_preprint":false},{"pmid":"18981230","id":"PMC_18981230","title":"The BH3-only protein Bik/Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFNgamma-induced cell death.","date":"2008","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18981230","citation_count":46,"is_preprint":false},{"pmid":"14633680","id":"PMC_14633680","title":"Enhancement of Bik antitumor effect by Bik mutants.","date":"2003","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/14633680","citation_count":45,"is_preprint":false},{"pmid":"12874789","id":"PMC_12874789","title":"Mutations of the BIK gene in human peripheral B-cell lymphomas.","date":"2003","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12874789","citation_count":44,"is_preprint":false},{"pmid":"21317312","id":"PMC_21317312","title":"Cigarette smoke suppresses Bik to cause epithelial cell hyperplasia and mucous cell metaplasia.","date":"2011","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21317312","citation_count":44,"is_preprint":false},{"pmid":"10419903","id":"PMC_10419903","title":"Expression of the death gene Bik/Nbk promotes sensitivity to drug-induced apoptosis in corticosteroid-resistant T-cell lymphoma and prevents tumor growth in severe combined immunodeficient mice.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10419903","citation_count":43,"is_preprint":false},{"pmid":"18025305","id":"PMC_18025305","title":"Mcl-1 determines the Bax dependency of Nbk/Bik-induced apoptosis.","date":"2007","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18025305","citation_count":43,"is_preprint":false},{"pmid":"11342619","id":"PMC_11342619","title":"Involvement of Bik, a proapoptotic member of the Bcl-2 family, in surface IgM-mediated B cell apoptosis.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11342619","citation_count":41,"is_preprint":false},{"pmid":"19219069","id":"PMC_19219069","title":"PAR bZIP-bik is a novel transcriptional pathway that mediates oxidative stress-induced apoptosis in fibroblasts.","date":"2009","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/19219069","citation_count":37,"is_preprint":false},{"pmid":"16007125","id":"PMC_16007125","title":"Caspase-independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk / Bik.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16007125","citation_count":34,"is_preprint":false},{"pmid":"12467227","id":"PMC_12467227","title":"The pro-apoptotic protein, Bik, exhibits potent antitumor activity that is dependent on its BH3 domain.","date":"2001","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/12467227","citation_count":33,"is_preprint":false},{"pmid":"17027756","id":"PMC_17027756","title":"Transcriptional activation of the proapoptotic bik gene by E2F proteins in cancer cells.","date":"2006","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17027756","citation_count":32,"is_preprint":false},{"pmid":"31703394","id":"PMC_31703394","title":"HDAC4 Levels Control Sensibility toward Cisplatin in Gastric Cancer via the p53-p73/BIK Pathway.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31703394","citation_count":32,"is_preprint":false},{"pmid":"28287102","id":"PMC_28287102","title":"Plumbagin sensitizes breast cancer cells to tamoxifen-induced cell death through GRP78 inhibition and Bik upregulation.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28287102","citation_count":30,"is_preprint":false},{"pmid":"27262843","id":"PMC_27262843","title":"Osteopontin-stimulated apoptosis in cardiac myocytes involves oxidative stress and mitochondrial death pathway: role of a pro-apoptotic protein BIK.","date":"2016","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27262843","citation_count":28,"is_preprint":false},{"pmid":"37750320","id":"PMC_37750320","title":"TMEM215 Prevents Endothelial Cell Apoptosis in Vessel Regression by Blunting BIK-Regulated ER-to-Mitochondrial Ca Influx.","date":"2023","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/37750320","citation_count":27,"is_preprint":false},{"pmid":"21063407","id":"PMC_21063407","title":"BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma.","date":"2010","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21063407","citation_count":26,"is_preprint":false},{"pmid":"11303912","id":"PMC_11303912","title":"GnRH-Bik/Bax/Bak chimeric proteins target and kill adenocarcinoma cells; the general use of pro-apoptotic proteins of the Bcl-2 family as novel killing components of targeting chimeric proteins.","date":"2000","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/11303912","citation_count":26,"is_preprint":false},{"pmid":"28986568","id":"PMC_28986568","title":"Bik reduces hyperplastic cells by increasing Bak and activating DAPk1 to juxtapose ER and mitochondria.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28986568","citation_count":25,"is_preprint":false},{"pmid":"31460837","id":"PMC_31460837","title":"Upregulation of miR-1306-5p decreases cerebral ischemia/reperfusion injury in vitro by targeting BIK.","date":"2019","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31460837","citation_count":25,"is_preprint":false},{"pmid":"25548100","id":"PMC_25548100","title":"Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells.","date":"2014","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/25548100","citation_count":24,"is_preprint":false},{"pmid":"10974546","id":"PMC_10974546","title":"Structural analysis of the human pro-apoptotic gene Bik: chromosomal localization, genomic organization and localization of promoter sequences.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10974546","citation_count":23,"is_preprint":false},{"pmid":"31387940","id":"PMC_31387940","title":"BIK ubiquitination by the E3 ligase Cul5-ASB11 determines cell fate during cellular stress.","date":"2019","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31387940","citation_count":21,"is_preprint":false},{"pmid":"28796811","id":"PMC_28796811","title":"Biphasic ROS production, p53 and BIK dictate the mode of cell death in response to DNA damage in colon cancer cells.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28796811","citation_count":20,"is_preprint":false},{"pmid":"24554662","id":"PMC_24554662","title":"Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.","date":"2014","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/24554662","citation_count":19,"is_preprint":false},{"pmid":"15953675","id":"PMC_15953675","title":"Suppression of pancreatic tumor progression by systemic delivery of a pancreatic-cancer-specific promoter driven Bik mutant.","date":"2005","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/15953675","citation_count":19,"is_preprint":false},{"pmid":"22513214","id":"PMC_22513214","title":"The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.","date":"2012","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/22513214","citation_count":17,"is_preprint":false},{"pmid":"25767602","id":"PMC_25767602","title":"Induction of BCL2-Interacting Killer, BIK, is Mediated for Anti-Cancer Activity of Curcumin in Human Head and Neck Squamous Cell Carcinoma Cells.","date":"2015","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25767602","citation_count":17,"is_preprint":false},{"pmid":"28412412","id":"PMC_28412412","title":"Autophagy regulatory molecule, TMEM74, interacts with BIK and inhibits BIK-induced apoptosis.","date":"2017","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/28412412","citation_count":15,"is_preprint":false},{"pmid":"30584337","id":"PMC_30584337","title":"MicroRNA 486-3p directly targets BIK and regulates apoptosis and invasion in colorectal cancer cells.","date":"2018","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30584337","citation_count":15,"is_preprint":false},{"pmid":"23991648","id":"PMC_23991648","title":"BH3-only proteins Noxa, Bik, Bmf, and Bid activate Bax and Bak indirectly when studied in yeast model.","date":"2013","source":"FEMS yeast research","url":"https://pubmed.ncbi.nlm.nih.gov/23991648","citation_count":15,"is_preprint":false},{"pmid":"28720543","id":"PMC_28720543","title":"BIK is involved in BRAF/MEK inhibitor induced apoptosis in melanoma cell lines.","date":"2017","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/28720543","citation_count":14,"is_preprint":false},{"pmid":"24100375","id":"PMC_24100375","title":"Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells.","date":"2013","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24100375","citation_count":14,"is_preprint":false},{"pmid":"29033852","id":"PMC_29033852","title":"Activation of Casein Kinase II by Gallic Acid Induces BIK-BAX/BAK-Mediated ER Ca++-ROS-Dependent Apoptosis of Human Oral Cancer Cells.","date":"2017","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29033852","citation_count":14,"is_preprint":false},{"pmid":"17064661","id":"PMC_17064661","title":"5-Aza-2'-deoxycytidine and depsipeptide synergistically induce expression of BIK (BCL2-interacting killer).","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17064661","citation_count":13,"is_preprint":false},{"pmid":"28784260","id":"PMC_28784260","title":"Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner.","date":"2017","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28784260","citation_count":13,"is_preprint":false},{"pmid":"34517787","id":"PMC_34517787","title":"Long non-coding RNA TUG1 knockdown prevents neurons from death to alleviate acute spinal cord injury via the microRNA-338/BIK axis.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34517787","citation_count":12,"is_preprint":false},{"pmid":"26437021","id":"PMC_26437021","title":"Bik Mediates Caspase-Dependent Cleavage of Viral Proteins to Promote Influenza A Virus Infection.","date":"2016","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26437021","citation_count":11,"is_preprint":false},{"pmid":"16514421","id":"PMC_16514421","title":"Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model.","date":"2006","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/16514421","citation_count":11,"is_preprint":false},{"pmid":"18299962","id":"PMC_18299962","title":"The endoplasmic reticulum (ER)-target protein Bik induces Hep3B cells apoptosis by the depletion of the ER Ca2+ stores.","date":"2008","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18299962","citation_count":11,"is_preprint":false},{"pmid":"22573037","id":"PMC_22573037","title":"Neither loss of Bik alone, nor combined loss of Bik and Noxa, accelerate murine lymphoma development or render lymphoma cells resistant to DNA damaging drugs.","date":"2012","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/22573037","citation_count":10,"is_preprint":false},{"pmid":"26059411","id":"PMC_26059411","title":"Bik subcellular localization in response to oxidative stress induced by chemotherapy, in Two different breast cancer cell lines and a Non-tumorigenic epithelial cell line.","date":"2015","source":"Journal of applied toxicology : JAT","url":"https://pubmed.ncbi.nlm.nih.gov/26059411","citation_count":10,"is_preprint":false},{"pmid":"38113109","id":"PMC_38113109","title":"Bik promotes proteasomal degradation to control low-grade inflammation.","date":"2023","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/38113109","citation_count":9,"is_preprint":false},{"pmid":"17636408","id":"PMC_17636408","title":"Mutant Bik gene transferred by cationic liposome inhibits peritoneal disseminated murine colon cancer.","date":"2007","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/17636408","citation_count":9,"is_preprint":false},{"pmid":"30133309","id":"PMC_30133309","title":"Biodistribution and Internal Radiation Dosimetry of 99mTc-IDA-D-[c(RGDfK)]2 (BIK-505), a Novel SPECT Radiotracer for the Imaging of Integrin αvβ3 Expression.","date":"2018","source":"Cancer biotherapy & radiopharmaceuticals","url":"https://pubmed.ncbi.nlm.nih.gov/30133309","citation_count":9,"is_preprint":false},{"pmid":"17574210","id":"PMC_17574210","title":"Apoptosis induced by BIK was decreased with RNA interference of caspase-12.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17574210","citation_count":9,"is_preprint":false},{"pmid":"36603764","id":"PMC_36603764","title":"Endoplasmic reticulum protein BIK binds to and inhibits mitochondria-localized antiapoptotic proteins.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36603764","citation_count":8,"is_preprint":false},{"pmid":"25165875","id":"PMC_25165875","title":"Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25165875","citation_count":8,"is_preprint":false},{"pmid":"22873408","id":"PMC_22873408","title":"BIK (NBK) is a mediator of the sensitivity of Fanconi anaemia group C lymphoblastoid cell lines to interstrand DNA cross-linking agents.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22873408","citation_count":7,"is_preprint":false},{"pmid":"26662110","id":"PMC_26662110","title":"Breast cancer cell line MDA-MB-231 miRNA profile expression after BIK interference: BIK involvement in autophagy.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26662110","citation_count":7,"is_preprint":false},{"pmid":"25463603","id":"PMC_25463603","title":"NS5B induces up-regulation of the BH3-only protein, BIK, essential for the hepatitis C virus RNA replication and viral release.","date":"2014","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/25463603","citation_count":7,"is_preprint":false},{"pmid":"19898928","id":"PMC_19898928","title":"BAK, BAX, and NBK/BIK proapoptotic gene alterations in Iranian patients with ataxia telangiectasia.","date":"2009","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19898928","citation_count":6,"is_preprint":false},{"pmid":"24637719","id":"PMC_24637719","title":"BikDDA, a mutant of Bik with longer half-life expression protein, can be a novel therapeutic gene for triple-negative breast cancer.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24637719","citation_count":6,"is_preprint":false},{"pmid":"38701194","id":"PMC_38701194","title":"MyoD1 promotes the transcription of BIK and plays an apoptosis-promoting role in the development of gastric cancer.","date":"2024","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/38701194","citation_count":5,"is_preprint":false},{"pmid":"37095508","id":"PMC_37095508","title":"Independent role of caspases and Bik in augmenting influenza A virus replication in airway epithelial cells and mice.","date":"2023","source":"Virology journal","url":"https://pubmed.ncbi.nlm.nih.gov/37095508","citation_count":5,"is_preprint":false},{"pmid":"35371316","id":"PMC_35371316","title":"Copy number amplification-activated long non-coding RNA LINC00662 epigenetically inhibits BIK by interacting with EZH2 to regulate tumorigenesis in non-small cell lung cancer.","date":"2022","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35371316","citation_count":5,"is_preprint":false},{"pmid":"25861752","id":"PMC_25861752","title":"Involvement of multiple cellular pathways in regulating resistance to tamoxifen in BIK-suppressed MCF-7 cells.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25861752","citation_count":5,"is_preprint":false},{"pmid":"26423071","id":"PMC_26423071","title":"Low BIK outside-inside-out interactive inflammation immune-induced transcription-dependent apoptosis through FUT3-PMM2-SQSTM1-SFN-ZNF384.","date":"2016","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/26423071","citation_count":4,"is_preprint":false},{"pmid":"24527759","id":"PMC_24527759","title":"The increase in BIK expression following ERK1/2 pathway inhibition is a consequence of G₁ cell-cycle arrest and not a direct effect on BIK protein stability.","date":"2014","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/24527759","citation_count":4,"is_preprint":false},{"pmid":"40627391","id":"PMC_40627391","title":"BIK polymorphism and proteasome regulation unveil host risk factor for severe influenza.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/40627391","citation_count":3,"is_preprint":false},{"pmid":"34741311","id":"PMC_34741311","title":"Casein kinase II activates Bik to induce death of hyperplastic mucous cells in a cell cycle-dependent manner.","date":"2021","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/34741311","citation_count":3,"is_preprint":false},{"pmid":"30250907","id":"PMC_30250907","title":"Does the BCL-2 family member BIK control lung carcinogenesis?","date":"2018","source":"Molecular & cellular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30250907","citation_count":3,"is_preprint":false},{"pmid":"34455510","id":"PMC_34455510","title":"Expression of bik cluster and production of bikaverin by Fusarium oxysporum f. sp. lycopersici grown using two alternate nitrogen sources.","date":"2021","source":"International microbiology : the official journal of the Spanish Society for Microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/34455510","citation_count":2,"is_preprint":false},{"pmid":"34962825","id":"PMC_34962825","title":"Rhomboid domain containing 1 promotes the growth of non-small cell lung cancer through the activation of EGFR and regulation of the BIK-mediated apoptosis.","date":"2021","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/34962825","citation_count":2,"is_preprint":false},{"pmid":"40825105","id":"PMC_40825105","title":"Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes.","date":"2025","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/40825105","citation_count":1,"is_preprint":false},{"pmid":"40971288","id":"PMC_40971288","title":"Polymorphism of BIK as a Host Risk Factor for Severe Influenza.","date":"2025","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/40971288","citation_count":1,"is_preprint":false},{"pmid":"38357926","id":"PMC_38357926","title":"Reduced Bik expression drives low-grade airway inflammation and increased risk for COPD in females.","date":"2024","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/38357926","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50062,"output_tokens":10160,"usd":0.151293,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20525,"output_tokens":6725,"usd":0.135375,"stage2_stop_reason":"end_turn"},"total_usd":0.286668,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"BIK was identified as a novel pro-apoptotic protein that interacts with anti-apoptotic proteins BCL-2, BCL-XL, EBV-BHRF1, and adenovirus E1B-19K via a conserved 9 amino acid BH3 domain. Death-promoting activity of BIK can be suppressed by co-expression of these survival proteins.\",\n      \"method\": \"Co-immunoprecipitation, yeast two-hybrid, transient transfection apoptosis assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal binding demonstrated by multiple methods (Co-IP and two-hybrid), replicated in subsequent papers across multiple labs\",\n      \"pmids\": [\"7478623\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"NBK/BIK was cloned from a yeast two-hybrid screen for proteins interacting with E1B 19K. It contains only BH3 (not BH1/BH2), interacts with BCL-2 and E1B 19K in vitro, co-localizes with cytoplasmic and nuclear membranes, antagonizes 19K-mediated inhibition of apoptosis, and induces apoptosis independently of BAX.\",\n      \"method\": \"Yeast two-hybrid, in vitro binding, transient transfection, co-localization, functional apoptosis assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods; independently replicated by other labs\",\n      \"pmids\": [\"8816500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Functional dissection showed that the BH3 domain of BIK (residues 57-74) is the core heterodimerization domain for BCL-2 and BCL-XL, but heterodimerization alone is insufficient for cell death; additional C-terminal sequences (residues 120-134 beyond the BH3) are required for efficient apoptotic activity.\",\n      \"method\": \"Deletion mutagenesis, yeast two-hybrid, co-immunoprecipitation, functional apoptosis assays in mammalian cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic mutagenesis with functional validation, clear structure-function dissection\",\n      \"pmids\": [\"9305912\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"BIK and BAK engage the apoptotic death pathway downstream of the CrmA block but upstream of the IAP (inhibitor of apoptosis) block, positioning them in the mid-stream of caspase activation cascade.\",\n      \"method\": \"Genetic epistasis using CrmA and IAP overexpression combined with BIK/BAK transfection and cell death assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean epistasis experiment, single lab, single method\",\n      \"pmids\": [\"9082997\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"BIK is a phosphoprotein phosphorylated at threonine 33 and serine 35. Mutation of these phosphorylation sites (T33A/S35A) reduces apoptotic activity without significantly affecting heterodimerization with BCL-2, indicating phosphorylation is required for efficient apoptotic function. Partial purification of kinase activity from HeLa cell cytoplasm suggests a casein kinase II-related enzyme phosphorylates BIK.\",\n      \"method\": \"Metabolic 32P labeling, site-directed mutagenesis, kinase assays, functional apoptosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct phosphorylation mapping by mutagenesis plus functional consequence, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"11084041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The human BIK gene is located at chromosome 22q13.3, spans ~19 kb, comprises 5 exons, and is expressed ubiquitously with elevated levels in heart and skeletal muscle. A minimal promoter was localized to -211 to +153 lacking TATA/CAAT boxes.\",\n      \"method\": \"FISH, genomic cloning, Northern blot, promoter-reporter transfection, deletion mutagenesis\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — FISH for chromosomal localization, functional promoter mapping by reporter assay\",\n      \"pmids\": [\"10974546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"BIK is an ER-resident protein (containing a C-terminal transmembrane segment) that stimulates cytochrome c release from mitochondria. A BH3-domain-dependent mechanism is required. Restricting BIK to the ER membrane with a cytochrome b5 anchor retains its cytochrome c release activity. ER BIK activity requires ER/light membrane fractions and cytosol in an in vitro reconstitution assay.\",\n      \"method\": \"Subcellular fractionation, membrane anchor replacement, in vitro reconstitution, cytochrome c release assay, BH3 mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution in vitro, mutagenesis, and organelle-targeting experiments; replicated by multiple subsequent papers\",\n      \"pmids\": [\"11884414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"BIK/NBK is transcriptionally induced downstream of E1A in a p53-dependent manner. BIK induces caspase-dependent cell death in p53-null cells. A BH3 point mutation abrogates BIK function. Endogenous and ectopic BIK associates with the endoplasmic reticulum.\",\n      \"method\": \"DNA microarray, RT-PCR, Western blot, subcellular fractionation, BH3 domain mutagenesis, apoptosis assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods in single lab; consistent with multiple independent studies\",\n      \"pmids\": [\"11971188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"NBK/BIK-induced apoptosis requires BAX but not BAK; BIK expression causes a conformational switch in BAX N-terminus, cytochrome c release, and mitochondrial permeability transition. Immunoprecipitation shows BIK interacts with BCL-XL and BCL-2 but NOT with BAX directly. BIK does not localize to mitochondria, suggesting it acts indirectly as a 'sensitizer' to trigger BAX-dependent apoptosis.\",\n      \"method\": \"Adenoviral tetracycline-regulated expression, BAX-knockout/reconstitution, immunoprecipitation, co-immunoprecipitation, conformational antibody assay, cytochrome c release assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO/reconstitution experiments with multiple orthogonal readouts; independently extended by other labs\",\n      \"pmids\": [\"12853473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ER-localized BIK activates a DRP1-dependent pathway that causes mitochondrial fragmentation and remodeling/opening of cristae (mobilizing intramitochondrial cytochrome c stores), distinct from DRP1's role in mitochondrial fission. BIK cooperates with the mitochondria-targeted BH3-only protein NOXA to activate BAX, causing rapid cytochrome c release and caspase activation, by a mechanism independent of DRP1 enzyme activity.\",\n      \"method\": \"Live cell imaging, selective digitonin permeabilization, dominant-negative DRP1, siRNA knockdown, co-expression experiments, cytochrome c localization\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods; functional dissection of DRP1 dependency; replicated in subsequent work\",\n      \"pmids\": [\"15791210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ER-localized BIK regulates BAX/BAK-dependent Ca2+ release from ER stores upstream of effector caspase activation. BIK-induced Ca2+ release is abolished in BAX/BAK double-deficient cells but restored by ectopic BAK. p53 stimulates BAK recruitment to the ER, which is inhibited by BIK siRNA. DRP1 (Ca2+-regulated GTPase) is involved in p53-induced mitochondrial fission and cytochrome c release.\",\n      \"method\": \"siRNA knockdown, BAX/BAK double-KO cells, intracellular Ca2+ measurements, subcellular fractionation, dominant-negative constructs\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO plus siRNA plus Ca2+ imaging; consistent with parallel EMBO J 2005 paper\",\n      \"pmids\": [\"15809295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Bortezomib stabilizes BIK protein from proteasomal degradation, leading to BIK accumulation that mediates apoptosis. BIK (and BIM) are required for bortezomib cytotoxicity; double-KO MEFs or cells with RNAi-mediated knockdown of both BIK and BIM are refractory to bortezomib. This establishes that BIK is normally degraded by the proteasome.\",\n      \"method\": \"Mouse embryo fibroblast double-KO, RNAi knockdown, Western blot, cell death assays\",\n      \"journal\": \"Molecular cancer therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO and siRNA in parallel; replicated across multiple cell lines and independently confirmed\",\n      \"pmids\": [\"15767553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NBK/BIK activates BAK-dependent apoptosis in response to protein synthesis inhibition by antagonizing/displacing BAK from MCL-1 and BCL-XL sequestration. NBK/BIK-deficient and BAK-deficient cells are resistant to MazF toxin and pharmacologic translation inhibition. NBK/BIK functions as the apical regulator of a BAK-dependent apoptotic pathway specifically in response to shutoff of protein synthesis.\",\n      \"method\": \"Genetic KO cells, reconstitution, co-immunoprecipitation (displacement of BAK from MCL-1/BCL-XL), adenoviral inducible expression, pharmacological inhibitors\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple KO cell lines, reconstitution, and mechanistic Co-IP demonstrating displacement of BAK\",\n      \"pmids\": [\"17403773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GRP78/BiP forms a complex with BIK at the ER. GRP78 overexpression decreases apoptosis induced by ER-targeted BIK and inhibits estrogen starvation-induced BAX activation and mitochondrial permeability transition. GRP78 interaction with BIK does not require the BH3 domain of BIK.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, overexpression, apoptosis assays, domain deletion analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, siRNA knockdown with functional rescue, domain mapping; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"17440086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BCL-2-null cells expressing BIK undergo caspase-independent cell death with autophagic features (cytosolic vacuoles, LC3 puncta, Beclin-1 upregulation, AIF nuclear redistribution) without cytochrome c release. This autophagic death is blocked by PI3K inhibitors (3-MA, wortmannin) or depletion of ATG5/Beclin-1.\",\n      \"method\": \"BCL-2 KO vs. WT MEFs, BIK overexpression, caspase inhibition, PI3K inhibitors, ATG5/Beclin-1 siRNA, electron microscopy, LC3 localization\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO background with multiple pharmacological and genetic interventions; single lab\",\n      \"pmids\": [\"17873911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MCL-1 determines the BAX dependency of NBK/BIK-induced apoptosis. MCL-1 binding to BAK persists after NBK expression and prevents BAK activation in BAX-deficient cells. Targeted knockdown of MCL-1 allows BAK activation by NBK/BIK. In contrast, PUMA can disrupt MCL-1-BAK interaction and activate both BAX and BAK.\",\n      \"method\": \"siRNA knockdown of MCL-1, co-immunoprecipitation (MCL-1-BAK interaction), BAX/BAK-deficient cells, inducible BIK/NBK expression\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic Co-IP plus genetic KO plus siRNA in single lab with multiple readouts\",\n      \"pmids\": [\"18025305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BIK inhibits nuclear translocation of phospho-ERK1/2 to mediate IFN-gamma-induced cell death in airway epithelial cells. BIK (but not BikL61G mutant) physically interacts with and suppresses nuclear translocation of phospho-ERK1/2. Loss of BIK suppresses IFN-gamma-induced death and leads to persistence of hyperplastic epithelial cells.\",\n      \"method\": \"Bik KO mice, overexpression, BikL61G mutant, co-immunoprecipitation, immunofluorescence (phospho-ERK1/2 nuclear localization), in vivo allergen model\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse model, mutagenesis showing L61G blocks interaction, reciprocal Co-IP, functional consequences in vivo\",\n      \"pmids\": [\"18981230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RHBDD1, a rhomboid family serine protease, cleaves BIK at a site within its transmembrane region. RHBDD1 residues G142 and S144 are essential for this proteolytic activity. RHBDD1 overexpression reduces BIK-mediated apoptosis; RHBDD1 knockdown enhances it. This cleavage is upstream of BIK protein degradation.\",\n      \"method\": \"Site-directed mutagenesis of RHBDD1, overexpression and siRNA knockdown, Western blot for BIK cleavage, apoptosis assays\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis of catalytic residues plus functional KD/OE; single lab\",\n      \"pmids\": [\"18953687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TGF-beta induces BIK transcription in human B cells via direct Smad binding to a consensus Smad-binding element in the BIK promoter, and simultaneously represses BCL-XL. BIK induction is required for TGF-beta-induced apoptosis; shRNA suppression of BIK diminishes it.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) for Smad binding at BIK promoter, promoter reporter assay, shRNA knockdown, overexpression\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct Smad binding plus functional reporter and shRNA; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"19136942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GRP78 forms a complex with BIK independent of the BH3 domain and competes with BCL-2 for BIK binding. Increased GRP78 expression decreases BIK-BCL-2 complex formation, thereby releasing BCL-2 from BIK sequestration. This mechanism confers endocrine resistance in breast cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, BH3 deletion mutants, overexpression/knockdown, apoptosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mapping with BH3 deletion, competitive Co-IP showing GRP78 displaces BCL-2 from BIK; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"21622563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BIK mRNA 3' end processing and expression are controlled by the nuclear poly(A) polymerase Star-PAP downstream of DNA damage signals. PKCdelta associates with the Star-PAP complex and is required for BIK expression. PIPKIalpha generates PI4,5P2 that directly stimulates PKCdelta activity in the Star-PAP complex. Features in the BIK 3' UTR define Star-PAP specificity and may block canonical PAP activity.\",\n      \"method\": \"siRNA/shRNA knockdown, co-immunoprecipitation, kinase assays, 3' end processing assays, reporter assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic pathway with multiple Co-IPs, kinase assays, and functional 3' processing assays in single rigorous study\",\n      \"pmids\": [\"22244330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Src tyrosine kinase inhibits apoptosis by increasing BIK degradation via activation of the Ras-Raf-MEK1/2-ERK1/2 pathway. ERK1/2 phosphorylates BIK on Thr124, which drives BIK ubiquitylation on Lys33 and subsequent proteasomal degradation.\",\n      \"method\": \"Phosphorylation site mapping by mutagenesis, ubiquitylation assays, proteasome inhibitor, ERK1/2 pathway inhibitors, v-Src transformed fibroblasts\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — phosphorylation and ubiquitylation site mapping by mutagenesis with functional consequence; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"22388352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Disruption of SQSTM1/p62 causes cargo loading failure and accumulation of NBK/Bik on ER membranes (by blocking autophagic degradation of NBK/Bik), leading to apoptosis. NBK/Bik knockdown markedly attenuates apoptosis caused by SQSTM1/p62 targeting. Autophagy initiation inhibitors (Ulk1, Beclin-1, Atg5 shRNA) substantially diminish NBK/Bik accumulation, while distal autophagy blockade enhances it.\",\n      \"method\": \"shRNA knockdown, co-immunoprecipitation, Western blot for ER-associated BIK, genetic/pharmacologic autophagy inhibition, in vivo xenograft\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic knockdowns and pharmacologic tools; single lab\",\n      \"pmids\": [\"25002530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BIK dissociates the BAK/BCL-2 complex to enrich for ER-associated BAK and interacts with the kinase domain of DAPk1, forming a BIK-DAPk1-ERK1/2-BAK complex. BIK disrupts the BCL-2-IP3R interaction to cause ER Ca2+ release. ER-associated BAK (enriched by BIK) interacts with DAPk1 calmodulin domain to increase ER-mitochondria contact sites and facilitate mitochondrial Ca2+ uptake. The BIK BH3 helix is sufficient for ER-BAK enrichment and ER Ca2+ release, but mitochondrial Ca2+ uptake also requires BAK.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, domain deletion analysis, Ca2+ imaging, ER-mitochondria contact site quantification, BIK peptide experiments, mouse allergen model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple Co-IPs, domain mapping, Ca2+ imaging, mouse in vivo model; comprehensive mechanistic study\",\n      \"pmids\": [\"28986568\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"p53 promotes apoptosis during prolonged ER stress by suppressing BiP/GRP78 expression via binding to the first 346-nt of the bip mRNA through a trans-suppression domain in the first 7 N-terminal amino acids of p53ΔN40. BiP suppression releases pro-apoptotic BIK from BiP, activating apoptosis.\",\n      \"method\": \"BiP mRNA binding assays, reporter assays, p53 isoform overexpression, siRNA knockdown, apoptosis assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mRNA binding assay, reporter assay, and functional siRNA; single lab\",\n      \"pmids\": [\"28622297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Cul5-ASB11 is the E3 ubiquitin ligase that targets BIK for ubiquitination and proteasomal degradation. During ER stress, XBP1s (activated by IRE1alpha) activates ASB11, which stimulates BIK ubiquitination, interaction with p97/VCP, and proteolysis, promoting cell survival during the adaptive phase. Genotoxic agents downregulate the IRE1alpha-XBP1s-ASB11 axis to stabilize BIK and promote apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, ASB11 siRNA/overexpression, IRE1alpha inhibitor, XBP1s overexpression, in vivo tumor model\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic Co-IP identifying E3 ligase, ubiquitination assays, pathway validation with multiple genetic/pharmacologic tools\",\n      \"pmids\": [\"31387940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Casein kinase IIalpha (CKIIalpha) is responsible for phosphorylating BIK at Thr33/Ser35 to activate it. CKIIalpha is expressed only during G2/M phase, causing BIK to selectively kill proliferating (S/G2/M) cells. BIK phosphorylation mutants at Thr33 or Ser35 demonstrated that phosphorylation activates BIK to induce death even in quiescent cells. BIK protein is detectable only in green (S/G2/M) cells using fluorescent ubiquitin cell cycle indicators.\",\n      \"method\": \"Fluorescent ubiquitin cell cycle indicators (FUCCI), co-immunoprecipitation, proteomics, phosphorylation site mutagenesis, CKIIalpha siRNA, airway epithelial cell cultures and mouse model\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — kinase identified by proteomics/Co-IP, confirmed by mutagenesis of phosphorylation sites with functional consequence; FUCCI cell cycle tracking\",\n      \"pmids\": [\"34741311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BIK, although predominantly ER-localized, can directly bind mitochondria-localized BCL-XL and BCL-2 via its BH3 region (detected by FLIM-FRET). In BMK-BAX/BAK DKO cells, a fraction of BIK moves toward mitochondria in response to mitochondria-localized BCL-XL. In MCF-7 cells, BIK is also present at mitochondria-associated ER membranes and binds mitochondria-localized BCL-XL via relocalization. This suggests BIK initiates mitochondrial outer membrane permeabilization via direct interactions at ER-mitochondria contact sites.\",\n      \"method\": \"FLIM-FRET microscopy, BH3 mutagenesis, BAX/BAK DKO cells, mitochondria-targeted BCL-XL chimeric mutants, subcellular localization imaging\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — FLIM-FRET for direct binding detection, BH3 mutagenesis as control, BAX/BAK DKO cells; rigorous single study\",\n      \"pmids\": [\"36603764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BIK deficiency causes low-grade inflammation and spontaneous emphysema in female but not male mice. Mechanistically, BIK modifies the BH4 domain of BCL-2 to interact with proteasome regulatory particles RPN1 and RPN2, enhancing proteasomal degradation of nuclear proteins (including nuclear p65). BCL-2 and BIK levels are lower in female vs. male mouse lung, explaining the sex-specific phenotype.\",\n      \"method\": \"Bik KO mouse model, transgenic airway BIK overexpression, co-immunoprecipitation (BIK-BCL-2, BIK-RPN1/RPN2), proteasomal degradation assays, nuclear/cytosolic fractionation, LPS/allergen models\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO and transgenic mouse models, mechanistic Co-IP identifying novel proteasome interaction via BCL-2 BH4 domain, multiple orthogonal readouts\",\n      \"pmids\": [\"38113109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TMEM215 forms a complex with BiP/GRP78, which in turn interacts with BIK. TMEM215 knockdown triggers BIK-dependent apoptosis in endothelial cells via increased mitochondria-associated ER membrane contacts and mitochondrial Ca2+ influx through IP3R and MCU. Inhibiting IP3R or MCU abrogates TMEM215 knockdown-induced apoptosis.\",\n      \"method\": \"Co-immunoprecipitation-mass spectrometry, siRNA knockdown, BIK siRNA rescue, Ca2+ imaging, IP3R/MCU inhibitors, EC-specific Tmem215 KO mouse\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — proteomic identification of complex, multiple genetic/pharmacologic validations, KO mouse model with in vivo phenotype\",\n      \"pmids\": [\"37750320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HCV NS5B RNA polymerase induces BIK expression and co-localizes and interacts with BIK by co-immunoprecipitation, suggesting BIK interacts with the HCV replication complex. BIK is required for efficient HCV RNA replication and viral release; BIK-depleted cells show significantly reduced viral replication.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence co-localization, siRNA knockdown, viral titer assays, BIK overexpression\",\n      \"journal\": \"Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and co-localization plus functional KD; single lab, mechanistic follow-up limited\",\n      \"pmids\": [\"25463603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BIK mediates caspase-dependent cleavage of influenza A virus (IAV) nucleoprotein (NP) and M2 proteins, and enables cytoplasmic export of viral ribonucleoprotein. Bik-deficient mouse AECs show attenuated IAV replication, reduced caspase-3 activation, and impaired viral NP/M2 cleavage. Bik-deficient mice are protected from IAV lethality.\",\n      \"method\": \"Bik KO mouse model, siRNA knockdown in human AECs, viral titer assays, Western blot for viral protein cleavage, caspase-3 activation, viral RNP nuclear export assays\",\n      \"journal\": \"American journal of respiratory cell and molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mouse model in vivo, siRNA in human cells, mechanistic dissection of viral protein cleavage; replicated in subsequent papers\",\n      \"pmids\": [\"26437021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"IAV nucleoprotein (NP) suppresses the β5 subunit of the proteasome, leading to BIK accumulation and enhanced viral replication. BIK interacts with NP, disrupting the BCL-2/NP interaction and promoting viral replication. β5 treatment dampens BIK levels and protects mice from IAV-induced morbidity. A BIK promoter SNP (rs738276) influences BIK expression and correlates with influenza severity.\",\n      \"method\": \"Co-immunoprecipitation (BIK-NP, BCL-2-NP), β5 subunit knockdown/treatment, BIK KO/overexpression mouse model, air-liquid interface primary cell cultures, human cohort genotyping\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic Co-IP identifying BIK-NP interaction, proteasome subunit manipulation, KO and transgenic mouse models, human cohort validation\",\n      \"pmids\": [\"40627391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TMEM74, a lysosome transmembrane protein, interacts with BIK via its transmembrane (TM) domains and the BH3 domain of BIK. TMEM74 co-localizes with BIK in subcellular organelles and inhibits BIK-induced apoptosis. TM domain-deficient TMEM74 mutant loses this inhibitory function.\",\n      \"method\": \"Co-immunoprecipitation, fluorescent co-localization, domain deletion analysis, apoptosis assays, knockdown\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP with domain mapping; single lab, functional consequence demonstrated\",\n      \"pmids\": [\"28412412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BIK mRNA levels are induced by fulvestrant via a p53-dependent but non-transcriptional mechanism (p53 transcriptional activity is not required, unlike for PUMA induction by doxorubicin). BIK protein is subject to rapid proteasomal degradation in some breast cancer cell lines.\",\n      \"method\": \"siRNA knockdown of p53, dominant-negative p53, reporter assay, BIK mRNA stability assay, proteasome inhibitor MG132, Western blot\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic approaches with functional readouts; single lab\",\n      \"pmids\": [\"17047080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"E2F transcription factors directly activate the BIK promoter, contributing to chemotherapy-induced BIK expression in cancer cells by a p53-independent mechanism. E2F-mediated BIK induction is required for efficient adriamycin-induced apoptosis.\",\n      \"method\": \"Promoter-reporter assays, ChIP, E2F overexpression and knockdown, apoptosis assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay demonstrating direct E2F binding; single lab\",\n      \"pmids\": [\"17027756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PAR bZIP transcription factors (TEF, DBP) directly activate the BIK promoter. In PAR bZIP triple-KO fibroblasts, bik is the only BH3-only gene downregulated. PAR bZIP proteins mediate oxidative stress (H2O2)-induced apoptosis through BIK, as confirmed by BIK knockdown rescue experiments.\",\n      \"method\": \"PAR bZIP triple-KO mouse fibroblasts, promoter-reporter assay, ChIP, BIK siRNA rescue, oxidative stress apoptosis assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, KO fibroblasts, functional rescue by siRNA; single lab\",\n      \"pmids\": [\"19219069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"BIK antitumor activity in vivo requires an intact BH3 domain. BH3 domain deletion abolishes cytochrome c release, caspase (9, 7, 3) activation, and tumor growth suppression in xenograft models.\",\n      \"method\": \"Adenoviral overexpression, BH3 deletion mutant, cytochrome c release assay, caspase activity, nude mouse xenograft\",\n      \"journal\": \"Molecular cancer therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean mutagenesis with both in vitro and in vivo functional validation; single lab\",\n      \"pmids\": [\"12467227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Bik and Bim show functional redundancy in eliminating supernumerary spermatogonia and spermatocytes during the first wave of spermatogenesis. Bik single-KO mice are fertile, but bik-/-bim-/- double-KO adult males are infertile with arrested spermatogenesis and increased early germ cells—a phenotype similar to Bax deficiency, placing Bik and Bim upstream of Bax.\",\n      \"method\": \"Bik-KO, Bim-KO, and Bik/Bim double-KO mouse generation, histology, fertility assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean double-KO mouse genetics demonstrating synthetic phenotype, epistasis with Bax\",\n      \"pmids\": [\"16270031\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BIK is a BH3-only pro-apoptotic protein predominantly residing in the endoplasmic reticulum membrane via its C-terminal transmembrane domain, where it initiates apoptosis by (1) releasing Ca2+ from ER stores in a BAX/BAK-dependent manner through disruption of BCL-2-IP3R interaction and enrichment of ER-associated BAK via a DAPk1 complex, (2) triggering DRP1-dependent mitochondrial cristae remodeling and cytochrome c mobilization, (3) directly binding anti-apoptotic proteins (BCL-2, BCL-XL, MCL-1) via its BH3 domain at ER-mitochondria contact sites to displace and activate BAX/BAK, (4) acting as a 'sensitizer' BH3-only protein that cooperates with effector BH3-only proteins (e.g., NOXA) for rapid cytochrome c release; its pro-apoptotic activity is governed by phosphorylation at Thr33/Ser35 by casein kinase IIalpha (active in G2/M), ubiquitination on Lys33 by Cul5-ASB11 E3 ligase targeting it for proteasomal degradation (regulated by the IRE1alpha-XBP1s axis during ER stress or by ERK1/2-phosphorylation of Thr124 downstream of oncogenic signaling), and inhibitory interaction with GRP78/BiP; additionally, BIK modifies BCL-2's BH4 domain to interact with proteasome subunits RPN1/RPN2 to promote degradation of nuclear proteins including NF-kB p65, thereby suppressing low-grade inflammation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"BIK (NBK) is a BH3-only pro-apoptotic member of the BCL-2 family that initiates the intrinsic apoptotic pathway from the endoplasmic reticulum, where it resides via a C-terminal transmembrane anchor [#1, #6, #7]. It was originally identified by its capacity to bind anti-apoptotic proteins BCL-2, BCL-XL, and viral homologs (EBV-BHRF1, adenovirus E1B-19K) through a conserved BH3 domain, the death-promoting activity of which is neutralized by these survival proteins [#0, #1]. Structure-function dissection established the BH3 region (residues 57–74) as the heterodimerization interface, while additional C-terminal sequences are required for efficient killing [#2, #37]. Rather than directly engaging effectors, BIK acts largely as a 'sensitizer': it does not bind BAX directly but displaces effectors such as BAK from MCL-1 and BCL-XL sequestration, and the resulting activation of BAX or BAK depends on cellular MCL-1 levels [#8, #12, #15]. From its ER station, BIK drives BAX/BAK-dependent Ca2+ release from ER stores and a DRP1-dependent remodeling of mitochondrial cristae that mobilizes cytochrome c, cooperating with mitochondrial BH3 proteins like NOXA for rapid cytochrome c release [#9, #10]; it can also relocalize to ER–mitochondria contact sites to directly bind mitochondrial BCL-XL/BCL-2 via its BH3 helix and assembles a BIK–DAPk1–ERK1/2–BAK complex that enriches ER-associated BAK and disrupts BCL-2–IP3R interaction to gate Ca2+ flux [#23, #27]. BIK is transcriptionally induced by diverse death stimuli—via E2F and p53 during genotoxic and oncogene stress, by TGF-beta/Smad and PAR bZIP factors, and through Star-PAP-dependent 3' end processing after DNA damage [#7, #18, #20, #35, #36]. Its activity is tightly restrained post-translationally: CKIIalpha phosphorylation at Thr33/Ser35 activates BIK in a cell-cycle-restricted manner, ERK1/2 phosphorylation at Thr124 promotes Lys33 ubiquitination, and the Cul5-ASB11 E3 ligase (regulated by the IRE1alpha-XBP1s axis) targets BIK for proteasomal degradation, while GRP78/BiP sequesters BIK at the ER independent of its BH3 domain [#4, #21, #25, #26, #19, #13]. Genetic evidence places BIK in physiological apoptosis—redundant with BIM upstream of BAX in spermatogenesis [#38]—and in IFN-gamma-driven clearance of airway epithelium and suppression of low-grade inflammation, the latter through a non-apoptotic role modifying the BCL-2 BH4 domain to recruit proteasome subunits RPN1/RPN2 for degradation of nuclear p65 [#16, #28]. BIK is also co-opted by viruses, being required for efficient HCV and influenza A virus replication [#30, #31, #32].\"\n  ,\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established BIK as a pro-apoptotic protein defined by a BH3 domain that physically engages anti-apoptotic BCL-2 family and viral survival proteins, framing it as a counter-regulator of cell survival machinery.\",\n      \"evidence\": \"Co-IP, yeast two-hybrid, and transient transfection apoptosis assays identifying BCL-2/BCL-XL/BHRF1/E1B-19K binding\",\n      \"pmids\": [\"7478623\", \"8816500\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve whether BIK acts directly on effectors or only sequesters anti-apoptotic proteins\", \"Subcellular site of action undefined\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Defined the BH3 (57–74) as the heterodimerization core but showed heterodimerization alone is insufficient for killing, implicating additional C-terminal determinants and positioning BIK in the mid-stream caspase cascade.\",\n      \"evidence\": \"Deletion mutagenesis with functional apoptosis assays; CrmA/IAP epistasis\",\n      \"pmids\": [\"9305912\", \"9082997\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular function of the C-terminal requirement not defined\", \"Epistasis placement based on single-method overexpression\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified BIK as a phosphoprotein whose apoptotic activity requires CKII-like phosphorylation at Thr33/Ser35, separating its killing function from its heterodimerization activity.\",\n      \"evidence\": \"Metabolic 32P labeling, phosphosite mutagenesis (T33A/S35A), partial kinase purification; genomic/promoter characterization\",\n      \"pmids\": [\"11084041\", \"10974546\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase identity not definitively established at this stage\", \"How phosphorylation activates BIK mechanistically unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Localized BIK action to the ER membrane and demonstrated it triggers mitochondrial cytochrome c release in a BH3-dependent, distance-acting manner; linked BIK induction to the E1A/p53 axis.\",\n      \"evidence\": \"Subcellular fractionation, membrane-anchor swap, in vitro reconstitution; microarray/RT-PCR for p53-dependent induction\",\n      \"pmids\": [\"11884414\", \"11971188\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The diffusible signal from ER to mitochondria not identified\", \"Effector dependency (BAX vs BAK) not resolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed BIK acts as a sensitizer requiring BAX—not directly binding it but driving its conformational activation—and confirmed BH3-dependent antitumor activity in vivo.\",\n      \"evidence\": \"BAX-KO/reconstitution, conformational antibody and cytochrome c assays, Co-IP; xenograft with BH3 deletion mutant\",\n      \"pmids\": [\"12853473\", \"12467227\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why BAK is dispensable in these settings unresolved\", \"Identity of the effector-activating intermediary unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Resolved the ER-to-mitochondria mechanism: BIK drives BAX/BAK-dependent ER Ca2+ release and a DRP1-dependent cristae remodeling that mobilizes cytochrome c, cooperating with NOXA for rapid release.\",\n      \"evidence\": \"Live-cell imaging, BAX/BAK DKO cells, dominant-negative/siRNA DRP1, Ca2+ imaging, selective permeabilization\",\n      \"pmids\": [\"15791210\", \"15809295\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How DRP1-independent cristae opening is mechanically achieved unclear\", \"Direct molecular link between Ca2+ release and effector activation incomplete\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated BIK is constitutively degraded by the proteasome and that proteasome inhibition (bortezomib) requires BIK for cytotoxicity, establishing protein stability as a key activity switch.\",\n      \"evidence\": \"BIK/BIM double-KO MEFs, RNAi, Western blot, cell death assays; in vivo spermatogenesis double-KO genetics\",\n      \"pmids\": [\"15767553\", \"16270031\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase responsible not yet identified\", \"Functional redundancy with BIM limits single-gene phenotype interpretation\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined how anti-apoptotic context dictates effector choice: BIK displaces BAK from MCL-1/BCL-XL, and MCL-1 levels determine whether BIK kills via BAX or BAK, particularly in response to translation shutoff.\",\n      \"evidence\": \"Genetic KO/reconstitution, displacement Co-IP, MCL-1 siRNA, BAX/BAK-deficient cells\",\n      \"pmids\": [\"17403773\", \"18025305\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative affinity hierarchy of BIK for different anti-apoptotic proteins not measured\", \"Stimulus specificity for translation inhibition mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified GRP78/BiP as a BH3-independent ER inhibitor of BIK and revealed a caspase-independent autophagic death program activated by BIK in BCL-2-null cells.\",\n      \"evidence\": \"Reciprocal Co-IP, domain mapping, siRNA rescue; BCL-2 KO MEFs with PI3K/ATG5/Beclin-1 interventions and EM\",\n      \"pmids\": [\"17440086\", \"17873911\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking BIK to autophagy machinery undefined\", \"Autophagic-death finding is Medium confidence, single lab\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Uncovered post-translational and proteolytic regulation: RHBDD1 cleaves BIK within its TM region, and BIK suppresses nuclear translocation of phospho-ERK1/2 to drive IFN-gamma-induced epithelial death in vivo.\",\n      \"evidence\": \"RHBDD1 catalytic-residue mutagenesis and KD/OE; Bik-KO mice, BikL61G mutant, Co-IP, immunofluorescence, allergen model\",\n      \"pmids\": [\"18953687\", \"18981230\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"RHBDD1 cleavage finding Medium confidence, single lab\", \"How a membrane-anchored BIK influences nuclear ERK trafficking is mechanistically unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Mapped transcriptional control of BIK to stimulus-specific factors: TGF-beta/Smad directly induces BIK while repressing BCL-XL, and PAR bZIP factors mediate oxidative-stress-induced apoptosis through BIK.\",\n      \"evidence\": \"ChIP, promoter reporters, shRNA/siRNA rescue; PAR bZIP triple-KO fibroblasts\",\n      \"pmids\": [\"19136942\", \"19219069\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Integration of multiple transcriptional inputs not reconciled\", \"PAR bZIP work single lab, Medium confidence\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Revealed two distinct regulatory layers: Star-PAP/PKCdelta/PIPKIalpha controls BIK mRNA 3' processing after DNA damage, and Src-Ras-ERK1/2 phosphorylation of Thr124 drives Lys33 ubiquitylation and degradation downstream of oncogenic signaling.\",\n      \"evidence\": \"siRNA, Co-IP, kinase and 3'-processing assays; phospho/ubiquitin site mapping in v-Src fibroblasts with proteasome and ERK inhibitors\",\n      \"pmids\": [\"22244330\", \"22388352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase acting downstream of Thr124 phosphorylation not identified here\", \"Cross-talk between transcriptional and degradative control undefined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Linked autophagy and an alternative GRP78 mechanism to BIK levels: SQSTM1/p62-mediated autophagy clears ER-associated BIK, and GRP78 competes with BCL-2 for BIK to confer endocrine resistance.\",\n      \"evidence\": \"shRNA, Co-IP, autophagy inhibitors, xenograft; competitive Co-IP with BH3-deletion mutants\",\n      \"pmids\": [\"25002530\", \"21622563\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contributions of autophagic vs proteasomal turnover not quantified\", \"p62 finding Medium confidence, single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Built a spatial model of BIK action at ER–mitochondria junctions: BIK assembles a BIK–DAPk1–ERK1/2–BAK complex, enriches ER-associated BAK, disrupts BCL-2–IP3R to release ER Ca2+, and connects p53 suppression of BiP to BIK release during ER stress.\",\n      \"evidence\": \"Co-IP, domain mapping, Ca2+ imaging, contact-site quantification, BIK peptides, allergen model; BiP mRNA binding/reporter assays for p53\",\n      \"pmids\": [\"28986568\", \"28622297\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and assembly order of the BIK–DAPk1–BAK complex undefined\", \"p53/BiP arm is Medium confidence\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified Cul5-ASB11 as the E3 ligase for BIK and integrated it into the ER-stress response: IRE1alpha-XBP1s activates ASB11 to degrade BIK during adaptive survival, while genotoxic stress downregulates this axis to stabilize BIK.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, ASB11/IRE1alpha manipulation, XBP1s overexpression, in vivo tumor model\",\n      \"pmids\": [\"31387940\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ASB11 substrate recognition is regulated unknown\", \"Relationship to Thr124-phosphorylation degradation pathway not reconciled\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified CKIIalpha as the activating kinase for BIK Thr33/Ser35 and showed its G2/M-restricted expression renders BIK a selective killer of proliferating cells.\",\n      \"evidence\": \"FUCCI cell-cycle tracking, proteomics/Co-IP, phosphosite mutagenesis, CKIIalpha siRNA, airway cells and mouse model\",\n      \"pmids\": [\"34741311\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for phospho-activation not solved\", \"Interplay with degradative phosphorylation events undefined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Established direct BIK–anti-apoptotic binding at mitochondria/ER-mitochondria contacts and uncovered a non-apoptotic role in which BIK directs BCL-2 BH4-mediated proteasomal degradation of nuclear p65 to suppress inflammation.\",\n      \"evidence\": \"FLIM-FRET, BH3 mutagenesis, BAX/BAK DKO and mito-targeted BCL-XL chimeras; Bik KO/transgenic mice, BIK-BCL-2/RPN1/RPN2 Co-IP, fractionation\",\n      \"pmids\": [\"36603764\", \"38113109\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How BIK toggles between pro-apoptotic and proteasome-recruiting modes unclear\", \"Basis of sex-specific BIK/BCL-2 expression not fully explained\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Connected BIK to ER-membrane sensing complexes, showing TMEM215-GRP78-BIK assemblies gate endothelial apoptosis via MAM Ca2+ flux through IP3R and MCU.\",\n      \"evidence\": \"Co-IP-MS, siRNA with BIK rescue, Ca2+ imaging, IP3R/MCU inhibitors, EC-specific Tmem215 KO mouse\",\n      \"pmids\": [\"37750320\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How TMEM215 loss liberates BIK from GRP78 mechanistically undefined\", \"Tissue specificity of this complex unexplored\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined a viral exploitation axis: influenza A and HCV co-opt BIK for replication, with IAV NP suppressing the proteasome to accumulate BIK and disrupting BCL-2/NP interactions, and a BIK promoter SNP correlating with influenza severity.\",\n      \"evidence\": \"Co-IP (BIK-NP, BCL-2-NP), proteasome subunit manipulation, BIK KO/transgenic mice, primary cultures, human cohort genotyping; earlier HCV NS5B and IAV NP/M2 cleavage studies\",\n      \"pmids\": [\"40627391\", \"26437021\", \"25463603\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which a pro-apoptotic protein aids viral replication not fully resolved\", \"HCV interaction is Medium confidence\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How BIK's molecular state is switched between its canonical pro-apoptotic effector-sensitizing function and its non-apoptotic proteasome-directing role, and how the competing activating phosphorylation, degradative phosphorylation/ubiquitination, and chaperone-sequestration inputs are integrated to set a death threshold, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of activated BIK at ER-mitochondria contacts\", \"Quantitative integration of opposing regulatory inputs not established\", \"Mechanistic basis for BIK promoting viral replication unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 2, 8, 12, 15]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [8, 12, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 6, 7, 13]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 1, 6, 8, 37]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [10, 23, 25]}\n    ],\n    \"complexes\": [\n      \"BIK-DAPk1-ERK1/2-BAK complex\",\n      \"TMEM215-GRP78-BIK complex\"\n    ],\n    \"partners\": [\n      \"BCL2\",\n      \"BCL2L1\",\n      \"MCL1\",\n      \"BAK1\",\n      \"HSPA5\",\n      \"DAPK1\",\n      \"ASB11\",\n      \"TMEM215\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}